Menu
 
Research menu
Jump to menu

Publications:  Prof Paolo Pozzilli

Leanza G, Maddaloni E, Pitocco D, Conte C, Palermo A, Maurizi AR, Pantano AL, Suraci C et al. (2019). Risk factors for fragility fractures in type 1 diabetes. Bone. vol. 125, 194-199.
10.1016/j.bone.2019.04.017
Strollo R, Vinci C, Napoli N, Fioriti E, Maddaloni E, Åkerman L, Casas R, Pozzilli P et al.(2019). Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies. Diabetes Metab Res Rev vol. 35, (4)
10.1002/dmrr.3132
Pozzilli P, Signore A(2019). The reconstructed natural history of type 1 diabetes mellitus. Nat Rev Endocrinol vol. 15, (5) 256-257.
10.1038/s41574-019-0192-8
Pozzilli P(2019). A tribute to Professor Domenico Andreani. Diabetes Metab Res Rev vol. 35, (3)
10.1002/dmrr.3136
Tabacco G, Naciu AM, Maggi D, Santonati A, Pedone C, Cesareo R, Bosco D, Gaspa G et al.(2019). Cardiovascular Autonomic Neuropathy as a New Complication of Postsurgical Chronic Hypoparathyroidism. J Bone Miner Res vol. 34, (3) 475-481.
10.1002/jbmr.3623
Lazzeri D, Pozzilli P(2018). Exophthalmos or pseudo-exophthalmos in the Last Judgement (1535-1541) by Michelangelo Buonarroti (1475-1564). J Endocrinol Invest vol. 41, (12) 1485-1486.
10.1007/s40618-018-0962-5
Pieralice S, Pozzilli P(2018). Latent Autoimmune Diabetes in Adults: A Review on Clinical Implications and Management. Diabetes Metab J vol. 42, (6) 451-464.
10.4093/dmj.2018.0190
Nusca A, Tuccinardi D, Albano M, Cavallaro C, Ricottini E, Manfrini S, Pozzilli P, Di Sciascio G(2018). Glycemic variability in the development of cardiovascular complications in diabetes. Diabetes Metab Res Rev vol. 34, (8)
10.1002/dmrr.3047
Cavallari I, Delli Veneri A, Maddaloni E, Melfi R, Patti G, Napoli N, Pozzilli P, Di Sciascio G(2018). Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes. Curr Diab Rep vol. 18, (12)
10.1007/s11892-018-1117-y
Palermo A, Capoluongo E, Del Toro R, Manfrini S, Pozzilli P, Maggi D, Defeudis G, Pantano F et al.(2018). A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins. Hormones (Athens) vol. 17, (3) 427-435.
10.1007/s42000-018-0044-2
Ibrahim M, Tuomilehto J, Aschner P, Beseler L, Cahn A, Eckel RH, Fischl AH, Guthrie G et al.(2018). Global status of diabetes prevention and prospects for action: A consensus statement. Diabetes Metab Res Rev vol. 34, (6)
10.1002/dmrr.3021
Leslie RD, Pozzilli P, Peters AL, Buzzetti R, Shankar SS, Milicevic Z, Pavo I, Lebrec J et al.(2018). Response to the comment on: "Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 trials". Diabetes Obes Metab vol. 20, (9) 2319-2320.
10.1111/dom.13366
Maddaloni E, Pozzilli P(2018). Diabetes: the disease of the 10 D. Endocrine vol. 61, (2) 353-354.
10.1007/s12020-017-1454-7
https://qmro.qmul.ac.uk/xmlui/handle/123456789/33583
Lazzeri D, Pozzilli P(2018). "Madonna of the carnation": Leonardo da Vinci (1452-1519). J Endocrinol Invest vol. 41, (7) 879-880.
10.1007/s40618-018-0842-z
Defeudis G, Fioriti E, Palermo A, Tuccinardi D, Minucci A, Capoluongo E, Pozzilli P, Manfrini S(2018). A case of pheochromocytoma with negative MIBG scintigraphy, PET-CT and genetic tests (VHL included) and a rare case of post-operative erectile dysfunction. Hormones (Athens) vol. 17, (2) 279-284.
10.1007/s42000-018-0037-1
Lauria Pantano A, Maddaloni E, Briganti SI, Beretta Anguissola G, Perrella E, Taffon C, Palermo A, Pozzilli P et al.(2018). Differences between ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules. Eur J Endocrinol vol. 178, (6) 595-603.
10.1530/EJE-18-0083
Pozzilli P, Leslie RD, Peters AL, Buzzetti R, Shankar SS, Milicevic Z, Pavo I, Lebrec J et al.(2018). Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 Trials. Diabetes Obes Metab vol. 20, (6) 1490-1498.
10.1111/dom.13237
Pozzilli P, Pieralice S(2018). Latent Autoimmune Diabetes in Adults: Current Status and New Horizons. Endocrinol Metab (Seoul) vol. 33, (2) 147-159.
10.3803/EnM.2018.33.2.147
https://qmro.qmul.ac.uk/xmlui/handle/123456789/51664
Grieco D, Palamà Z, Borrelli A, De Ruvo E, Sciarra L, Scarà A, Goanta E, Calabrese V et al.(2018). Diabetes mellitus and atrial remodelling in patients with paroxysmal atrial fibrillation: Role of electroanatomical mapping and catheter ablation. Diab Vasc Dis Res vol. 15, (3) 185-195.
10.1177/1479164117752492
Ricottini E, Mangiacapra F, Nusca A, Melfi R, Cavallari I, Miglionico M, Gallo P, Pozzilli P et al.(2018). Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty. Am J Cardiol vol. 121, (9) 1027-1031.
10.1016/j.amjcard.2018.01.013
Napoli N, Strollo R, Defeudis G, Leto G, Moretti C, Zampetti S, D'Onofrio L, Campagna G et al.(2018). Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults. J Clin Endocrinol Metab vol. 103, (5) 1921-1928.
10.1210/jc.2017-02274
Defeudis G, Khazrai YM, Di Rosa C, Secchi C, Montedoro A, Maurizi AR, Palermo A, Pozzilli P et al.(2018). Conversation Maps™, an effective tool for the management of males and females with type 2 diabetes and mildly impaired glycemic control. Hormones (Athens) vol. 17, (1) 113-117.
10.1007/s42000-018-0005-9
Naciu AM, Pozzilli P(2018). Novel blood glucose lowering therapies for managing type 1 diabetes in paediatric patients. Expert Opin Pharmacother vol. 19, (4) 355-364.
10.1080/14656566.2018.1441288
Maurizi AR, Piemonte V, Pozzilli P(2018). Diabetes on demand and novel technologies. Diabetes Metab Res Rev vol. 34, (2)
10.1002/dmrr.2985
Writing Group for the TRIGR Study Group, Knip M, Åkerblom HK, Al Taji E, Becker D, Bruining J, Castano L, Danne T et al.(2018). Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial. JAMA vol. 319, (1) 38-48.
10.1001/jama.2017.19826
Palermo A, Fosca M, Tabacco G, Marini F, Graziani V, Santarsia MC, Longo F, Lauria A et al.(2018). Raman Spectroscopy Applied to Parathyroid Tissues: A New Diagnostic Tool to Discriminate Normal Tissue from Adenoma. Anal Chem vol. 90, (1) 847-854.
10.1021/acs.analchem.7b03617
Pozzilli P(2018). Fast publication, a must for a journal. Diabetes Metab Res Rev vol. 34, (1)
10.1002/dmrr.2978
Pozzilli P(2018). In memoriam. Diabetes Metab Res Rev vol. 34, (1)
10.1002/dmrr.2956
Garg SK, Henry RR, Banks P, Buse JB, Davies MJ, Fulcher GR, Pozzilli P, Gesty-Palmer D et al.(2017). Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes. N Engl J Med vol. 377, (24) 2337-2348.
10.1056/NEJMoa1708337
Piemonte V, Capocelli M, De Santis L, Maurizi AR, Pozzilli P(2017). A Novel Three-Compartmental Model for Artificial Pancreas: Development and Validation. Artif Organs vol. 41, (12) E326-E336.
10.1111/aor.12980
Rau JV, Fosca M, Graziani V, Taffon C, Rocchia M, Caricato M, Pozzilli P, Onetti Muda A et al.(2017). Proof-of-concept Raman spectroscopy study aimed to differentiate thyroid follicular patterned lesions. Sci Rep vol. 7, (1) 14970-14970.
10.1038/s41598-017-14872-1
https://qmro.qmul.ac.uk/xmlui/handle/123456789/33647
Quercia S, Turroni S, Fiori J, Soverini M, Rampelli S, Biagi E, Castagnetti A, Consolandi C et al.(2017). Gut microbiome response to short-term dietary interventions in reactive hypoglycemia subjects. Diabetes Metab Res Rev vol. 33, (8)
10.1002/dmrr.2927
Maddaloni E, Pastore G, Del Buono MG, Porcari A, Fittipaldi M, Garilli F, Tiberti C, Angeletti S et al.(2017). High Prevalence of Autoimmune Diabetes and Poor Glycaemic Control among Adults in Madagascar: A Brief Report from a Humanitarian Health Campaign in Ambanja. J Diabetes Res vol. 2017, 3860674-3860674.
10.1155/2017/3860674
https://qmro.qmul.ac.uk/xmlui/handle/123456789/33444
Guglielmi C, Del Toro R, Lauria A, Maurizi AR, Fallucca S, Cappelli A, Angeletti S, Lachin JM et al.(2017). Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes. Diabetes Metab Res Rev vol. 33, (6)
10.1002/dmrr.2899
Maddaloni E, Strollo R, Pozzilli P, Napoli N (2017). Effect of calcidiol on insulin resistance and beta cell function in subjects with pre-diabetes. DIABETOLOGIA. vol. 60, S252-S252.
Pozzilli P, Leslie RD, Peters A, Buzzetti R, Shankar SS, Milicevic Z, Pavo I, Lebrec J et al. (2017). Reduction of HbA1c with dulaglutide in type 2 diabetes (T2D) patients negative, low positive or high positive for GAD antibodies (GADA): a post hoc analysis of AWARD-2,-4 and-5. DIABETOLOGIA. vol. 60, S68-S68.
Del Toro R, Maddaloni E, Fioriti E, Tabacco G, Defeudis G, Caggiano C, Manfrini S, Pozzilli P (2017). Valsalva test alone is the best and economically valued tool for diagnosing cardiac autonomic neuropathy. DIABETOLOGIA. vol. 60, S458-S458.
Strollo R, Vinci C, Napoli N, Pozzilli P, Ludvigsson J, Nissim A(2017). Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children. Diabetologia vol. 60, (8) 1467-1474.
10.1007/s00125-017-4296-1
Napoli N, Strollo R, Paladini A, Briganti SI, Pozzilli P, Epstein S(2017). Corrigendum to "The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes". Int J Endocrinol vol. 2017, Article 5924671, 5924671-5924671.
10.1155/2017/5924671
https://qmro.qmul.ac.uk/xmlui/handle/123456789/35007
Pozzilli P, Norwood P, Jódar E, Davies MJ, Ivanyi T, Jiang H, Woodward DB, Milicevic Z(2017). Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9). Diabetes Obes Metab vol. 19, (7) 1024-1031.
10.1111/dom.12937
Pozzilli P, Cappa M(2017). SLEEPING CUPID BY CARAVAGGIO: WHAT DIAGNOSIS?. Endocr Pract vol. 23, (7) 881-884.
10.4158/EP171854.CO
Maurizi AR, Maddaloni E, Del Toro R, Pieralice S, Fioriti E, Manfrini S, Pozzilli P (2017). An Automated Bolus Calculator for the Control of Glucose Variability in Type 1 Diabetes. DIABETES. vol. 66, A238-A238.
Strollo R, Vinci C, Napoli N, Pozzilli P, Ludvigsson J, Nissim A (2017). Antibodies to Posttranslationally Modified Insulin for Prediction of Type 1 Diabetes in Children. DIABETES. vol. 66, A58-A58.
Leanza G, Maddaloni E, Pitocco D, Strollo R, Pozzilli P, Napoli N (2017). Association between Glycemic Control and the Occurrence of the First Fragility Fracture in Type 1 Diabetes. DIABETES. vol. 66, A463-A463.
Maddaloni E, Del Toro R, Fioriti E, Tabacco G, Defeudis G, Caggiano C, Manfrini S, Pozzilli P (2017). Cardiac Autonomic Neuropathy Is Efficiently Diagnosed by Valsalva Maneuver Alone. DIABETES. vol. 66, A150-A150.
Maddaloni E, Strollo R, Del Toro R, Pozzilli P, Napoli N (2017). Effect of Calcidiol on Insulin Resistance and beta-Cell Function in Subjects with Prediabetes. DIABETES. vol. 66, A349-A349.
Pantano AL, Nusca A, Del Toro R, Maddaloni E, Borrelli E, Zappia L, Proscia C, Melfi R et al. (2017). Glycemic Variability Assessed by Continuous Glucose Monitoring and Antiplatelet Responsiveness in Patients Undergoing Coronary Stenting: Results from the Observational Glyvar Study. DIABETES. vol. 66, A243-A243.
Strollo R, Soare A, Manon Khazrai Y, Di Mauro A, Palermo A, Del Toro R, Fallucca S, Giovanna Belluomo M et al.(2017). Increased sclerostin and bone turnover after diet-induced weight loss in type 2 diabetes: a post hoc analysis of the MADIAB trial. Endocrine vol. 56, (3) 667-674.
10.1007/s12020-016-1171-7
Khazrai YM, Fioriti E, Lattanzi G, Pozzilli P, Manfrini S (2017). Person-Centered Approach: A Valuable Tool for the Management of Type 2 Diabetes. DIABETES. vol. 66, A183-A183.
Pantano AL, Nusca A, Del Toro R, Maddaloni E, Borrelli E, Zappia L, Proscia C, Melfi R et al. (2017). Pleiotropic Effects of Ranolazine in Diabetic Patients Undergoing Percutaneous Coronary Intervention: Preliminary Results of an Observational, Prospective Study. DIABETES. vol. 66, A592-A592.
Pozzilli P, Leslie RD, Peters A, Buzzetti R, Milicevic Z, Pavo I, Lebrec J, Martin S et al. (2017). Reduction of A1c with Dulaglutide in Type 2 Diabetes (T2D) Patients Positive or Negative for GAD Antibodies (GADA): A Post-hoc Analysis of AWARD-2,-4, and-5. DIABETES. vol. 66, A287-A287.
Palermo A, Tuccinardi D, D'Onofrio L, Watanabe M, Maggi D, Maurizi AR, Greto V, Buzzetti R et al.(2017). Vitamin K and osteoporosis: Myth or reality?. Metabolism vol. 70, 57-71.
10.1016/j.metabol.2017.01.032
Maurizi AR, Menduni M, Del Toro R, Kyanvash S, Maggi D, Guglielmi C, Pantano AL, Defeudis G et al.(2017). A pilot study of D-chiro-inositol plus folic acid in overweight patients with type 1 diabetes. Acta Diabetol vol. 54, (4) 361-365.
10.1007/s00592-016-0954-x
Soare A, Khazrai YM, Fontana L, Del Toro R, Lazzaro MC, Di Rosa C, Buldo A, Fioriti E et al.(2017). Treatment of reactive hypoglycemia with the macrobiotic Ma-pi 2 diet as assessed by continuous glucose monitoring: The MAHYP randomized crossover trial. Metabolism vol. 69, 148-156.
10.1016/j.metabol.2017.01.023
Rizzo P, Pitocco D, Zaccardi F, Di Stasio E, Strollo R, Rizzi A, Scavone G, Costantini F et al.(2017). Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus. Diabetes Metab Res Rev vol. 33, (2)
10.1002/dmrr.2839
Pozzilli P, Napoli N, Naciu AM, Soare A (2017). PRESENT AND FUTURE OF THE RELATIONSHIP BETWEEN GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS AND INSULIN FOR THE TREATMENT OF TYPE 2 DIABETES. INTERDIAB 2017: DIABETES MELLITUS IN INTERNAL MEDICINE. 78-85.
Pozzilli P, Lazzeri D(2016). A Goiter in Christ in Crucifixion. Thyroid vol. 26, (11) 1646-1647.
10.1089/thy.2016.0006
Schloot NC, Pham MN, Hawa MI, Pozzilli P, Scherbaum WA, Schott M, Kolb H, Hunter S et al.(2016). Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11. Diabetes Care vol. 39, (11) 1932-1939.
10.2337/dc16-0293
https://qmro.qmul.ac.uk/xmlui/handle/123456789/22373
Palermo A, Mangiameli G, Tabacco G, Longo F, Pedone C, Briganti SI, Maggi D, Vescini F et al.(2016). PTH(1-34) for the Primary Prevention of Postthyroidectomy Hypocalcemia: The THYPOS Trial. J Clin Endocrinol Metab vol. 101, (11) 4039-4045.
10.1210/jc.2016-2530
Rau JV, Graziani V, Fosca M, Taffon C, Rocchia M, Crucitti P, Pozzilli P, Onetti Muda A et al.(2016). RAMAN spectroscopy imaging improves the diagnosis of papillary thyroid carcinoma. Sci Rep vol. 6,
10.1038/srep35117
Maddaloni E, Cavallari I, De Pascalis M, Keenan H, Park K, Manfrini S, Buzzetti R, Patti G et al.(2016). Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects. Am J Cardiol vol. 118, (6) 822-827.
10.1016/j.amjcard.2016.06.044
Mangiacapra F, Panaioli E, Colaiori I, Ricottini E, Lauria Pantano A, Pozzilli P, Barbato E, Di Sciascio G(2016). Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients). Circulation vol. 134, (11) 835-837.
10.1161/CIRCULATIONAHA.116.023743
Giorgino F, Bonadonna RC, Gentile S, Vettor R, Pozzilli P(2016). Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists. Diabetes Metab Res Rev vol. 32, (6) 497-511.
10.1002/dmrr.2775
Soare A, Del Toro R, Khazrai YM, Di Mauro A, Fallucca S, Angeletti S, Skrami E, Gesuita R et al.(2016). A 6-month follow-up study of the randomized controlled Ma-Pi macrobiotic dietary intervention (MADIAB trial) in type 2 diabetes. Nutrition & Diabetes vol. 6, (8) e222-e222.
10.1038/nutd.2016.29
Mangiacapra F, Panaioli E, Colaiori I, Ricottini E, Pantano AL, Pozzilli P, Barbato E, Di Sciascio G (2016). CLOpidogrel versus TIcagreLor for antiplatelet maintenance in DIAbetic patients treated with percutaneous coronary intervention: results of the CLOTILDIA study. EUROPEAN HEART JOURNAL. vol. 37, 385-385.
Pozzilli P, Norwood P, Jodar E, Davies M, Ivanyi T, Jiang H, Woodward B, Milicevic Z (2016). Improved glycaemic control and weight loss with once weekly dulaglutide versus placebo, both added to titrated daily insulin glargine in type 2 diabetes patients (AWARD-9). DIABETOLOGIA. vol. 59, S75-S75.
Khazrai Y, Soare A, Fontana L, Del Toro R, Lazzaro M, Di Rosa C, Buldo A, Fioriti E et al. (2016). Treatment of reactive hypoglycaemia with macrobiotic Ma-Pi 2 diet for prevention of type 2 diabetes: the MAHYP randomised crossover trial. DIABETOLOGIA. vol. 59, S334-S335.
Maddaloni E, Pozzilli P(2016). Why China guidelines for type 2 diabetes represent an opportunity for treating this disease. Diabetes Metab Res Rev vol. 32, (5) 438-439.
10.1002/dmrr.2825
Candela M, Biagi E, Soverini M, Consolandi C, Quercia S, Severgnini M, Peano C, Turroni S et al.(2016). Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet. Br J Nutr vol. 116, (1) 80-93.
10.1017/S0007114516001045
https://qmro.qmul.ac.uk/xmlui/handle/123456789/34343
Nicoli F, Pozzilli P, Lazzeri D(2016). "The Penitent Magdalene": Tiziano Vecellio (1488/1490-1576). J Endocrinol Invest vol. 39, (7) 835-836.
10.1007/s40618-016-0436-6
Maurizi AR, Anda N, Del Toro R, Pantano AL, Fioriti E, Manfrini S, Pozzilli P (2016). A Bolus Advisor System for the Management of Insulin Therapy in Type 1 Diabetes. DIABETES. vol. 65, A227-A228.
Epstein S, Defeudis G, Manfrini S, Napoli N, Pozzilli P, Scientific Committee of the First International Symposium on Diabetes and Bone(2016). Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition. Osteoporos Int vol. 27, (6) 1931-1951.
10.1007/s00198-015-3454-x
Zanoboni L, Leanza G, Pitocco D, Costantino F, Schwartz AV, Pozzilli P, Napoli N (2016). Importance of Medical Nutrition Therapy on Long-Term Glycemic Control in Type 1 Diabetes Patients. DIABETES. vol. 65, A559-A560.
Pozzilli P, Norwood P, Jodar E, Ivanyi T, Jiang H, Woodward B, Milicevic Z (2016). Improved Glycemic Control and Weight Loss with Once-Weekly Dulaglutide vs. Placebo, Both Added to Titrated Daily Insulin Glargine, in Type 2 Diabetes Patients (AWARD-9). DIABETES. vol. 65, A62-A62.
Khazrai YM, Maurizi AR, Piccirilli S, Pipolo G, Costantino F, Pozzilli P, Manfrini S (2016). Person-Centred Approach Counselling: A Useful Tool to Reduce Burden of Care in Adolescents with Type 1 Diabetes. DIABETES. vol. 65, A177-A177.
Del Toro R, Maddaloni E, Montedoro A, Lauria A, Maurizi AR, Guglielmi C, Manfrini S, Pozzilli P (2016). Risk Factors for Cardiac Autonomic Neuropathy: The Role of HDL. DIABETES. vol. 65, A149-A149.
Strollo R, Soare A, Khazrai YM, Del Toro R, Fallucca S, Di Mauro A, Pozzilli P, Napoli N (2016). The Effect of Diet-induced Weight Loss on Bone Turnover in Patients with Type 2 Diabetes. DIABETES. vol. 65, A195-A195.
Palermo A, Tuccinardi D, Defeudis G, Watanabe M, D'Onofrio L, Lauria Pantano A, Napoli N, Pozzilli P et al.(2016). BMI and BMD: The Potential Interplay between Obesity and Bone Fragility. Int J Environ Res Public Health vol. 13, (6)
10.3390/ijerph13060544
Guglielmi C, Williams SR, Del Toro R, Pozzilli P(2016). Efficacy and safety of otelixizumab use in new-onset type 1 diabetes mellitus. Expert Opin Biol Ther vol. 16, (6) 841-846.
10.1080/14712598.2016.1180363
Amed S, Pozzilli P(2016). Diagnosis of diabetes type in children and young people: challenges and recommendations. Lancet Diabetes Endocrinol vol. 4, (5) 385-386.
10.1016/S2213-8587(16)00080-2
Buzzetti R, Pozzilli P, Frederich R, Iqbal N, Hirshberg B(2016). Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA). Diabetes Metab Res Rev vol. 32, (3) 289-296.
10.1002/dmrr.2717
Modesti PA, Omboni S, Taddei S, Ghione S, Portaluppi F, Pozzilli P, Volpe M, Arca M et al.(2016). Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: a double-blind, randomized study. J Hypertens vol. 34, (3) 576-587.
10.1097/HJH.0000000000000805
Pozzilli P (2016). CSII AND OTHER TECHNOLOGIES FOR PREVENTING BETA CELL FAILURE IN TYPE 2 DIABETES. DIABETES TECHNOLOGY & THERAPEUTICS. vol. 18, A1-A2.
Maddaloni E, D'Onofrio L, Pozzilli P(2016). Frailty and geography: should these two factors be added to the ABCDE contemporary guide to diabetes therapy?. Diabetes Metab Res Rev vol. 32, (2) 169-175.
10.1002/dmrr.2762
Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E(2016). Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev vol. 32, (1) 21-39.
10.1002/dmrr.2653
Dang MN, Bradford CM, Pozzilli P, Leslie RD(2016). Methylation Analysis in Distinct Immune Cell Subsets in Type 1 Diabetes. Methods Mol Biol vol. 1433, 143-151.
10.1007/7651_2015_286
Maurizi AR, Suraci C, Pitocco D, Schiaffini R, Tubili C, Morviducci L, Giordano R, Manfrini S et al.(2016). Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience. J Diabetes vol. 8, (1) 41-44.
10.1111/1753-0407.12321
Strollo R, Vinci C, Arshad MH, Perrett D, Tiberti C, Chiarelli F, Napoli N, Pozzilli P et al.(2015). Antibodies to post-translationally modified insulin in type 1 diabetes. Diabetologia vol. 58, (12) 2851-2860.
10.1007/s00125-015-3746-x
Lazzeri D, Pozzilli P, Persichetti P(2015). Endocrinology and art: "The Annunciation"-Girolamo Francesco Maria Mazzola called Parmigianino (1503-1540). J Endocrinol Invest vol. 38, (11) 1247-1248.
10.1007/s40618-015-0358-8
Weng J, Pozzilli P(2015). Hot topics on diabetes in China. Diabetes Metab Res Rev vol. 31, (8) 779-780.
10.1002/dmrr.2766
Defeudis G, Gianfrilli D, Di Emidio C, Pofi R, Tuccinardi D, Palermo A, Lenzi A, Pozzilli P(2015). Erectile dysfunction and its management in patients with diabetes mellitus. Rev Endocr Metab Disord
10.1007/s11154-015-9321-4
Barchetta I, Guglielmi C, Bertoccini L, Calella D, Manfrini S, Secchi C, Pozzilli P, Cavallo MG et al.(2015). Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic control. Acta Diabetol vol. 52, (5) 873-880.
10.1007/s00592-015-0721-4
Strollo R, Vinci C, Arshad MH, Perrett D, Tiberti C, Chiarelli F, Napoli N, Pozzilli P et al. (2015). Autoantibodies to posttranslationally modified insulin in type 1 diabetes. DIABETOLOGIA. vol. 58, S102-S103.
Maurizi A, Del Toro R, Menduni M, Pantano AL, Kyanvash S, Manfrini S, Pozzilli P (2015). D-chiro-inositol improves metabolic control in overweight patients with type 1 diabetes. DIABETOLOGIA. vol. 58, S255-S256.
Maddaloni E, Lessan N, Al Tikriti T, Buzzetti R, Pozzilli P, Barakat MT(2015). Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement (vol 10, e0131837, 2015). PLOS ONE vol. 10, (8) Article ARTN e0137152,
10.1371/journal.pone.0137152
Palermo A, D'Onofrio L, Eastell R, Schwartz AV, Pozzilli P, Napoli N(2015). Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review. Osteoporos Int vol. 26, (8) 2073-2089.
10.1007/s00198-015-3123-0
Napoli N, Mazzanti F, Giambra E, Strollo R, Mottini G, Pozzilli P (2015). Prevalent Gestational Diabetes Mellitus in HIV-Infected and -Uninfected Pregnant Women Living in Sub-Saharan Africa. DIABETES. vol. 64, A381-A381.
Napoli N, Strollo R, Defeudis G, Leto G, Hawa MI, Leslie RDG, Pozzilli P, Buzzetti R et al. (2015). Serum Sclerostin and Bone Turnover in Relation to Metabolic Syndrome in Patients with Type 2 Diabetes or LADA. DIABETES. vol. 64, A129-A129.
Defeudis G, Di Emidio C, Strollo R, Rinati MV, Tuccinardi D, Palermo A, Angeletti S, Manfrini S et al. (2015). The Efficacy of Continuous Glucose Monitoring to Improve BMI and Glycaemic Control in Prediabetes: The OBIG Trial. DIABETES. vol. 64, A240-A240.
Pozzilli P, Maddaloni E, Buzzetti R(2015). Combination immunotherapies for type 1 diabetes mellitus. Nat Rev Endocrinol vol. 11, (5) 289-297.
10.1038/nrendo.2015.8
Lazzeri D, Pozzilli P, Zhang YX, Persichetti P(2015). Goiter in paintings by Rogier van der Weyden (1399-1464). Thyroid vol. 25, (5) 559-562.
10.1089/thy.2014.0494
Elias D, Avron A, Tamir M, Eren R, Peled D, Dagan S, Raz I, Pozzilli P et al.(2015). Retraction Note: Abstracts of the 50th Annual Meeting of the EASD, Vienna 2014. 'Evaluation of DiaPep277(®) treatment in type 1 diabetes by integrated analysis'. Diabetologia vol. 58, (5)
10.1007/s00125-015-3542-7
Khazrai YM, Buzzetti R, Del Prato S, Cahn A, Raz I, Pozzilli P(2015). The addition of E (Empowerment and Economics) to the ABCD algorithm in diabetes care. J Diabetes Complications vol. 29, (4) 599-606.
10.1016/j.jdiacomp.2015.03.004
Signore A, Capriotti G, Chianelli M, Bonanno E, Galli F, Catalano C, Quintero AM, De Toma G et al.(2015). Detection of insulitis by pancreatic scintigraphy with 99mTc-labeled IL-2 and MRI in patients with LADA (Action LADA 10). Diabetes Care vol. 38, (4) 652-658.
10.2337/dc14-0580
Palermo A, Strollo R, Maddaloni E, Tuccinardi D, D'Onofrio L, Briganti SI, Defeudis G, De Pascalis M et al.(2015). Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity. Clin Endocrinol (Oxf) vol. 82, (4) 615-619.
10.1111/cen.12672
Lauria A, Barker A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, Mauricio D, Nordwall M et al.(2015). BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children. Eur J Endocrinol vol. 172, (2) 107-113.
10.1530/EJE-14-0522
Maddaloni E, Sabatino F, Del Toro R, Crugliano S, Grande S, Lauria Pantano A, Maurizi AR, Palermo A et al.(2015). In vivo corneal confocal microscopy as a novel non-invasive tool to investigate cardiac autonomic neuropathy in Type 1 diabetes. Diabet Med vol. 32, (2) 262-266.
10.1111/dme.12583
Pozzilli P (2015). THE IMPACT OF NEW TECHNOLOGY IN TYPE 2 DIABETES. DIABETES TECHNOLOGY & THERAPEUTICS. vol. 17, A2-A2.
Hernandez M, Mollo A, Marsal JR, Esquerda A, Capel I, Puig-Domingo M, Pozzilli P, de Leiva A et al.(2015). Insulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9. BMC Endocr Disord vol. 15,
10.1186/1472-6823-15-1
Pozzilli P (2015). ARE THE NEW ANTIDIABETIC DRUGS SIMPLIFYING OR COMPLICATING THE TYPE 2 DIABETES MANAGEMENT?. INTERDISCIPLINARY APPROACHES IN DIABETIC CHRONIC KIDNEY DISEASE. 25-27.
(2015). Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal. Diabetes Care 2014;37:1384-1391. DOI: 10.2337/dc13-1392. Diabetes Care vol. 38, (1)
10.2337/dc15-rt01a
Nusca A, Lauria Pantano A, Melfi R, Proscia C, Maddaloni E, Contuzzi R, Mangiacapra F, Palermo A et al.(2015). Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study. J Diabetes Res vol. 2015,
10.1155/2015/250201
Maddaloni E, Lessan N, Al Tikriti A, Buzzetti R, Pozzilli P, Barakat MT(2015). Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement. PLoS One vol. 10, (8)
10.1371/journal.pone.0131837
Ibrahim M, Abu Al Magd M, Annabi FA, Assaad-Khalil S, Ba-Essa EM, Fahdil I, Karadeniz S, Meriden T et al.(2015). Recommendations for management of diabetes during Ramadan: update 2015. BMJ Open Diabetes Res Care vol. 3, (1)
10.1136/bmjdrc-2015-000108
Soare A, Del Toro R, Roncella E, Khazrai YM, Angeletti S, Dugo L, Fallucca S, Fontana L et al.(2015). The effect of macrobiotic Ma-Pi 2 diet on systemic inflammation in patients with type 2 diabetes: a post hoc analysis of the MADIAB trial. BMJ Open Diabetes Res Care vol. 3, (1)
10.1136/bmjdrc-2014-000079
(2015). Treatment of recent-onset type 1 diabetic patients with DiaPep277: results of a double-blind, placebo-controlled, randomized phase 3 trial. Diabetes Care 2014;37:1392-1400. DOI: 10.2337/dc13-1391. Diabetes Care vol. 38, (1)
10.2337/dc15-rt01
Palermo A, Strollo R, Papalia R, D'Onofrio L, Maddaloni E, Briganti SI, Napoli N, Vespasiani U et al.(2014). Severe hypophosphatemic osteomalacia secondary to fanconi syndrome due to adefovir: a case report. Endocr Pract vol. 20, (12) e246-e249.
10.4158/EP14251.CR
Aronson R, Gottlieb PA, Christiansen JS, Donner TW, Bosi E, Bode BW, Pozzilli P, DEFEND Investigator Group(2014). Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes. Diabetes Care vol. 37, (10) 2746-2754.
10.2337/dc13-0327
Weng J, Pozzilli P(2014). Diabetes Metabolism: Research and Reviews--Chinese Diabetes Society special issue: a small but encouraging step toward the successful control of diabetes in China. Diabetes Metab Res Rev vol. 30, (6) 445-446.
10.1002/dmrr.2579
Elias D, Avron A, Tamir M, Eren R, Peled D, Dagan S, Raz I, Pozzilli P et al. (2014). Evaluation of DiaPep277 (R) treatment in type 1 diabetes by integrated analysis. DIABETOLOGIA. vol. 57, S190-S191.
Guglielmi C, Valente L, Fallucca S, Angeletti S, Briganti S, De Pascalis M, Lachin JM, Pozzilli P (2014). Glucagon and mixed-meal tests to estimate beta cell and incretin functions in normals: relevance for studies in type 1 diabetes. DIABETOLOGIA. vol. 57, S189-S189.
Proscia C, Nusca A, Melfi R, Pantano AL, Maddaloni E, Contuzzi R, Campanale CM, Pozzilli P et al. (2014). Glycemic variability assessed by continuous glucose monitoring and its correlation with renal and myocardial damage after coronary stenting. EUROPEAN HEART JOURNAL. vol. 35, 394-395.
Buzzetti R, Pozzilli P, Frederich R, Iqbal N, Hirshberg B (2014). Increase in beta cell function and improvement in HOMA-2beta index induced by saxagliptin in patients with latent autoimmune diabetes in adults. DIABETOLOGIA. vol. 57, S355-S355.
Maddaloni E, D'Onofrio L, Lauria A, Maurizi AR, Strollo R, Palermo A, Napoli N, Angeletti S et al.(2014). Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes. J Endocrinol Invest vol. 37, (7) 661-666.
10.1007/s40618-014-0092-7
Mitrea A, Fallucca S, Angeletti S, Soare A, Vernieri F, Ursini F, Trotta L, Mota M et al. (2014). Adipokines: The Missing Link between Alzheimer's Disease and Type 2 Diabetes?. DIABETES. vol. 63, A487-A487.
Khazrai YM, Defeudis G, Di Rosa C, Roncella E, Secchi C, Pozzilli P, Manfrini S (2014). Conversation Maps (TM), an Effective Tool for Type 2 Diabetes Treatment. DIABETES. vol. 63, A178-A179.
Guglielmi C, Secchi C, Maddaloni E, Manfrini S, Pozzilli P (2014). Effects of Treatment with Proton Pump Inhibitors on Metabolic Control in Patients with Type 2 Diabetes. DIABETES. vol. 63, A615-A615.
Guglielmi C, Valente L, Fallucca S, Angeletti S, Lachin JM, Pozzilli P (2014). Glucagon and Mixed-Meal Tests to Evaluate Beta-Cell Function and Incretin Axis: Relevance for Immunointervention Trials in Type 1 Diabetes. DIABETES. vol. 63, A75-A75.
Maddaloni E, Lessan N, Al Tikriti A, Pozzilli P, Barakat MT (2014). Prevalence and Features of Adult-Onset Autoimmune Diabetes in the United Arab Emirates (UAE). DIABETES. vol. 63, A399-A399.
Pozzilli P, Buzzetti R, Frederich R, Iqbal N, Hirshberg B (2014). Saxagliptin Increases beta-Cell Function and Improves HOMA Index in Patients with Latent Autoimmune Diabetes in Adults. DIABETES. vol. 63, A41-A41.
Soare A, Manon KY, Silvia A, Dugo L, Fallucca S, Fontana L, Altomare M, Gesuita R et al. (2014). The Effect of Macrobiotic (Ma-Pi 2) Diet on Systemic Inflammation in Patients with Type 2 Diabetes. DIABETES. vol. 63, A192-A192.
Piccirilli S, Khazrai YM, Soare A, Buzzetti R, Pozzilli P (2014). Wrist Circumference, a Simple and Economic Marker for Obese Type 2 Diabetes Subjects. DIABETES. vol. 63, A634-A634.
Hawa MI, Kolb H, Schloot N, Beyan H, Paschou SA, Buzzetti R, Mauricio D, De Leiva A et al.(2014). Adult- Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7. Diabetes Care 2013; 36: 908- 913. DIABETES CARE vol. 37, (5) 1494-1494.
10.2337/dc14-er05
Maddaloni E, Pozzilli P(2014). SMART diabetes: the way to go (Safe and Multifactorial Approach to reduce the Risk for Therapy in diabetes). Endocrine vol. 46, (1) 3-5.
10.1007/s12020-013-0128-3
Maddaloni E, Capolupo G, Palermo A, Manfrini S, Di Matteo FM, Grasso RF, Coppola R, Pozzilli P(2014). Continuous glucose monitoring and robot surgery of an insulinoma: a case report and review of the literature. Pancreas vol. 43, (3) 483-485.
10.1097/MPA.0000000000000040
Barker A, Lauria A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, Mauricio D, Nordwall M et al.(2014). Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study. Diabetes Obes Metab vol. 16, (3) 262-267.
10.1111/dom.12216
Soare A, Weiss EP, Pozzilli P(2014). Benefits of caloric restriction for cardiometabolic health, including type 2 diabetes mellitus risk. Diabetes Metab Res Rev vol. 30 Suppl 1, 41-47.
10.1002/dmrr.2517
Pozzilli P, Fallucca F(2014). Diet and diabetes: a cornerstone for therapy INTRODUCTION. DIABETES-METABOLISM RESEARCH AND REVIEWS vol. 30, 1-3.
Pozzilli P, Fallucca F(2014). Diet and diabetes: a cornerstone for therapy. Diabetes Metab Res Rev vol. 30 Suppl 1, 1-3.
10.1002/dmrr.2512
Khazrai YM, Defeudis G, Pozzilli P(2014). Effect of diet on type 2 diabetes mellitus: a review. Diabetes Metab Res Rev vol. 30 Suppl 1, 24-33.
10.1002/dmrr.2515
Khazrai YM, Maddaloni E, Altomare M, Cacciapaglia F, Pozzilli P(2014). New technologies aiding dietary programmes for weight control: the oral glucose spray. Endocrine vol. 45, (2) 288-292.
10.1007/s12020-013-9987-x
Pozzilli P, Strollo R, Bonora E(2014). One size does not fit all glycemic targets for type 2 diabetes. JOURNAL OF DIABETES INVESTIGATION vol. 5, (2) 134-141.
10.1111/jdi.12206
Palermo A, Maggi D, Maurizi AR, Pozzilli P, Buzzetti R(2014). Prevention of type 2 diabetes mellitus: is it feasible?. Diabetes Metab Res Rev vol. 30 Suppl 1, 4-12.
10.1002/dmrr.2513
Maddaloni E, Pozzilli P(2014). Comment on: "Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results". Nutr Metab Cardiovasc Dis vol. 24, (1)
10.1016/j.numecd.2013.06.007
Pozzilli P, Raz I, Peled D, Elias D, Avron A, Tamir M, Eren R, Dagan S et al.(2014). Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal. Diabetes Care vol. 37, (5) 1384-1391.
10.2337/dc13-1392
Napoli N, Strollo R, Paladini A, Briganti SI, Pozzilli P, Epstein S(2014). The alliance of mesenchymal stem cells, bone, and diabetes. Int J Endocrinol vol. 2014,
10.1155/2014/690783
Soare A, Khazrai YM, Del Toro R, Roncella E, Fontana L, Fallucca S, Angeletti S, Formisano V et al.(2014). The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial. Nutr Metab (Lond) vol. 11,
10.1186/1743-7075-11-39
Raz I, Ziegler AG, Linn T, Schernthaner G, Bonnici F, Distiller LA, Giordano C, Giorgino F et al.(2014). Treatment of recent-onset type 1 diabetic patients with DiaPep277: results of a double-blind, placebo-controlled, randomized phase 3 trial. Diabetes Care vol. 37, (5) 1392-1400.
10.2337/dc13-1391
Pedone C, Napoli N, Pozzilli P, Lauretani F, Bandinelli S, Ferrucci L, Rossi FF, Antonelli-Incalzi R(2013). Bone health as a function of adipokines and vitamin D pattern in elderly patients. Rejuvenation Res vol. 16, (6) 467-474.
10.1089/rej.2013.1436
Mollo A, Hernandez M, Marsal JR, Esquerda A, Rius F, Blanco-Vaca F, Verdaguer J, Pozzilli P et al.(2013). Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain (vol 29, pg 446, 2013). DIABETES-METABOLISM RESEARCH AND REVIEWS vol. 29, (8) 693-693.
10.1002/dmrr.2476
Levetan C, Pozzilli P, Jovanovic L, Schatz D(2013). Proposal for generating new beta cells in a muted immune environment for type 1 diabetes. Diabetes Metab Res Rev vol. 29, (8) 604-606.
10.1002/dmrr.2435
Mollo A, Hernandez M, Marsal JR, Esquerda A, Rius F, Blanco-Vaca F, Verdaguer J, Pozzilli P et al.(2013). Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain. Diabetes Metab Res Rev vol. 29, (6) 446-451.
10.1002/dmrr.2411
Buzzetti R, Pozzilli P, Frederich R, Iqbal N, Hirshberg B (2013). Saxagliptin improves glycaemic control and is well tolerated in adult diabetes patients with glutamic acid decarboxylase antibodies. DIABETOLOGIA. vol. 56, S390-S390.
Pozzilli P, Raz I, Linn T, Bonnici F, Elias D, Avron A, Tamir M, Eren R et al. (2013). Subgroup analysis of DIA-AID 1, an immune intervention phase 3 study in newly diagnosed type 1 diabetes patients. DIABETOLOGIA. vol. 56, S230-S230.
Maurizi AR, Pozzilli P(2013). Do we need continuous glucose monitoring in type 2 diabetes?. Diabetes Metab Res Rev
10.1002/dmrr.2450
Mannucci E, Dicembrini I, Lauria A, Pozzilli P(2013). Is glucose control important for prevention of cardiovascular disease in diabetes?. Diabetes Care vol. 36 Suppl 2, S259-S263.
10.2337/dcS13-2018
Strollo R, Ponchel F, Malmström V, Rizzo P, Bombardieri M, Wenham CY, Landy R, Perret D et al.(2013). Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis. Arthritis Rheum vol. 65, (7) 1702-1712.
10.1002/art.37964
Khazrai YM, De Gara L, Iorio B, Pozzilli P (2013). Dietary Habits and Undiagnosed Diabetes in a Rural Population of Peru. DIABETES. vol. 62, A699-A699.
Dagan S, Avron A, Peled D, Elias D, Tamir M, Pozzilli P, Raz I, Harari G et al. (2013). Differences in Long-Term Changes in C-peptide Levels after Stimulation With Glucagon or a Mixed-Meal. DIABETES. vol. 62, A64-A64.
Pham TMN, Burkart V, Hawa MI, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum W et al. (2013). Higher Serum Concentrations of TGF beta 1 in Patients With Type 1 Diabetes than in Patients With Type 2 Diabetes or Latent Autoimmune Diabetes in Adults. DIABETES. vol. 62, A447-A447.
Maddaloni E, Sabatino F, Del Toro R, Grande S, Palermo A, Lauria A, Maurizi A, Manfrini S et al. (2013). In-Vivo Corneal Confocal Microscopy as a Novel Non-Invasive Tool to Study Autonomic Nerve Function in Type 1 Diabetes. DIABETES. vol. 62, A145-A146.
Briganti SI, Guglielmi C, Tomao E, Avallone V, Cataldo R, Manfrini S, Pozzilli P (2013). Obesity and Diabetes in Military and Civil Aviation Flying Personnel. DIABETES. vol. 62, A708-A709.
Pozzilli P, Buzzetti R, Frederich R, Iqbal N, Hirshberg B (2013). Saxagliptin Is Well Tolerated and Improves Glycemic Control in Adult Diabetes Patients With GAD Antibodies. DIABETES. vol. 62, A287-A287.
Pham TMN, Kolb H, Zivehe F, Battelino T, Ludvigsson J, Pozzilli P, Burkart V, Roden M et al. (2013). Serum Concentrations of Adiponectin Associated Positively With Proinflammatory Cytokines in Patients With Type 1 Diabetes. DIABETES. vol. 62, A64-A64.
Hessner M, Kaldunski M, Jia S, Wang X, Cheong S, Pickersgill L, De Koning E, Ziegler A-G et al. (2013). Serum Signature Analysis of Participants of the Anti-Interleukin-1 in Diabetes Action (AIDA) Trial. DIABETES. vol. 62, A63-A64.
Pozzilli P, Raz I, Linn T, Bonnici F, Elias D, Avron A, Tamir M, Eren R et al. (2013). Subgroup Analysis of DIA-AID 1, an Immune Intervention Phase III Study in Newly Diagnosed Type 1 Diabetes Patients. DIABETES. vol. 62, A64-A64.
Rizzo P, Pitocco D, Scavone G, Di Stasio E, Costantini F, Strollo R, Galli M, Pozzilli P et al. (2013). The Role of Collagen Neoepitopes Generated by Oxidative Stress in the Pathogenesis of Charcot Neuroarthropathy. DIABETES. vol. 62, A619-A619.
Bonafini B, Pozzilli P(2013). The Three Graces: canons of beauty or disease repulsion. Int J Cardiol vol. 166, (2) 283-285.
10.1016/j.ijcard.2013.01.174
Chon S, Lee YJ, Fraterrigo G, Pozzilli P, Choi MC, Kwon M-K, Chin SO, Rhee SY et al.(2013). Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus. Diabetes Technol Ther vol. 15, (6) 455-460.
10.1089/dia.2012.0315
Pham MN, Kolb H, Battelino T, Ludvigsson J, Pozzilli P, Zivehe F, Roden M, Mandrup-Poulsen T et al.(2013). Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes. Diabetologia vol. 56, (6) 1356-1363.
10.1007/s00125-013-2883-3
Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Greenbaum CJ, Herold KC et al.(2013). Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet vol. 381, (9881) 1905-1915.
10.1016/S0140-6736(13)60023-9
Portuesi R, Cherubini C, Gizzi A, Buzzetti R, Pozzilli P, Filippi S(2013). A stochastic mathematical model to study the autoimmune progression towards type 1 diabetes. Diabetes Metab Res Rev vol. 29, (3) 194-203.
10.1002/dmrr.2382
Strollo R, Rizzo P, Spoletini M, Landy R, Hughes C, Ponchel F, Napoli N, Palermo A et al.(2013). HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus. Diabetologia vol. 56, (3) 563-572.
10.1007/s00125-012-2780-1
Pham MN, Kolb H, Mandrup-Poulsen T, Battelino T, Ludvigsson J, Pozzilli P, Roden M, Schloot NC et al.(2013). Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin. Diabetes Metab Res Rev vol. 29, (2) 166-170.
10.1002/dmrr.2378
Portuesi R, Pozzilli P, Boehm B, Buzzetti R, Filippi S(2013). Assessment of type 1 diabetes risk conferred by HLA-DRB1, INS-VNTR and PTPN22 genes using the Bayesian network approach. PLoS One vol. 8, (11)
10.1371/journal.pone.0079506
Napoli N, Strollo R, Pitocco D, Bizzarri C, Maddaloni E, Maggi D, Manfrini S, Schwartz A et al.(2013). Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes. PLoS One vol. 8, (2)
10.1371/journal.pone.0056488
https://qmro.qmul.ac.uk/xmlui/handle/123456789/5299
Dang MN, Buzzetti R, Pozzilli P(2013). Epigenetics in autoimmune diseases with focus on type 1 diabetes. Diabetes Metab Res Rev vol. 29, (1) 8-18.
10.1002/dmrr.2375
Guglielmi C, Palermo A, Pozzilli P(2012). Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy. Diabetes Metab Res Rev vol. 28 Suppl 2, 40-46.
10.1002/dmrr.2345
Bodrova TA, Kostyushev DS, Antonova EN, Slavin S, Gnatenko DA, Bocharova MO, Legg M, Pozzilli P et al.(2012). Introduction into PPPM as a new paradigm of public health service: an integrative view. EPMA J vol. 3, (1)
10.1186/1878-5085-3-16
Vaccaro O, Masulli M, Bonora E, Del Prato S, Giorda CB, Maggioni AP, Mocarelli P, Nicolucci A et al.(2012). Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial. Nutr Metab Cardiovasc Dis vol. 22, (11) 997-1006.
10.1016/j.numecd.2012.09.003
Cardwell CR, Stene LC, Ludvigsson J, Rosenbauer J, Cinek O, Svensson J, Perez-Bravo F, Memon A et al.(2012). Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studies. Diabetes Care vol. 35, (11) 2215-2225.
10.2337/dc12-0438
Palermo A, Napoli N, Maddaloni E, Lauria A, Soare A, Manfrini S, Altomare M, Leotta S et al. (2012). Buccal spray insulin in subjects with impaired glucose tolerance: improvement in HbA(1c) is lost after 6 months wash out therapy. DIABETOLOGIA. vol. 55, S53-S53.
Dagan S, Peled D, Elias D, Avron A, Eren R, Raz I, Pozzilli P (2012). Evaluation of treatment effect of a type 1 diabetes intervention therapy using GST versus MMTT. DIABETOLOGIA. vol. 55, S192-S192.
Raz I, Linn T, Ziegler A-G, Schernthaner G, Bonnici F, Eren R, Elias D, Dagan S et al. (2012). Recent data from DIA-AID 1, a global phase III clinical study using DiaPep277 (R) for the treatment of newly diagnosed type 1 diabetes patients. DIABETOLOGIA. vol. 55, S66-S66.
Khazrai YM, Cacciapaglia F, Palermo A, Pozzilli P(2012). The use of a glucose spray device to control progression towards hypoglycaemia. Endocrine vol. 42, (2) 442-444.
10.1007/s12020-012-9620-4
Pozzilli P, Strollo R(2012). Immunotherapy for Type 1 diabetes: getting beyond a negative first impression. Immunotherapy vol. 4, (7) 655-658.
10.2217/imt.12.54
Barker A, Lauria A, Schloot N, Hosszufalusi N, Panczel P, Ludvigsson J, Mathieu C, Mauricio D et al. (2012). BMI is the Major Driver of Beta Cell Loss in RecentOnset Type 1 Diabetes: a Multicentre, Longitudinal Study. DIABETES. vol. 61, A447-A447.
Palermo A, Maddaloni E, Pozzilli P(2012). Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?. Expert Opin Biol Ther vol. 12, (6) 767-772.
10.1517/14712598.2012.675324
Napoli N, Strollo R, Pitocco D, Bizzarri C, Maddaloni E, Maggi D, Manfrini S, Schwartz A et al. (2012). Calcitriol and Bone Turnover in Type 1 Diabetic Adolescents. DIABETES. vol. 61, A331-A331.
Khazrai YM, Defeudis G, Cutolo S, Pasqualotto E, Pozzilli P, Manfrini S (2012). Conversation Maps: The Path Towards Self-Management. DIABETES. vol. 61, A179-A179.
Leslie RD, Hawa MI, Kolb H, Schloot N, Beyan H, Paschou SA, Buzzetti R, Mauricio D et al. (2012). LADA is not a Distinct Form of Autoimmune Diabetes. DIABETES. vol. 61, A24-A25.
Dagan S, Ziegler AG, Pozzilli P, Linn T, Schernthaner G, Bonnici F, Elias D, Eren R et al. (2012). Recent Data from DIA-AID 1, a Global Phase III Clinical Study in Newly Diagnosed Type 1 Diabetes Patients. DIABETES. vol. 61, A76-A76.
Strom A, Menart B, Simon M-C, Pham MN, Kolb H, Roden M, Pozzilli P, Leslie RDG et al.(2012). Cellular interferon-γ and interleukin-13 immune reactivity in type 1, type 2 and latent autoimmune diabetes: action LADA 6. Cytokine vol. 58, (2) 148-151.
10.1016/j.cyto.2012.01.002
Roth J, Pozzilli P(2012). Editors' note to Raz and Eldor's commentary "Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms". Diabetes Metab Res Rev 2012. Diabetes Metab Res Rev vol. 28, (4)
10.1002/dmrr.2267
Pham MN, Hawa MI, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum WA, Seissler J et al.(2012). Increased serum concentrations of adhesion molecules but not of chemokines in patients with Type 2 diabetes compared with patients with Type 1 diabetes and latent autoimmune diabetes in adult age: action LADA 5. Diabet Med vol. 29, (4) 470-478.
10.1111/j.1464-5491.2011.03546.x
Bonafini B, Pozzilli P(2012). Scrotal asymmetry, varicocoele and the Riace Bronzes. Int J Androl vol. 35, (2) 181-182.
10.1111/j.1365-2605.2011.01181.x
Bizzarri C, Pinto RM, Pitocco D, Astorri E, Cappa M, Hawa M, Giannone G, Palermo A et al.(2012). Diabetes-related autoantibodies in children with acute lymphoblastic leukemia. Diabetes Care vol. 35, (3)
10.2337/dc11-1946
https://qmro.qmul.ac.uk/xmlui/handle/123456789/19616
Robert JJ, Ludvigsson J, Krisky D, Casas R, Battelino T, Castano L, Greening J, Kordonouri O et al.(2012). Treatment with GAD65 antigen in type 1 diabetes diagnosed recently. DIABETES & METABOLISM vol. 38, A130-A130.
10.1016/S1262-3636(12)71523-9
Ludvigsson J, Krisky D, Casas R, Battelino T, Castaño L, Greening J, Kordonouri O, Otonkoski T et al.(2012). GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med vol. 366, (5) 433-442.
10.1056/NEJMoa1107096
Hawa MI, Kolb H, Schloot N, Beyan H, Paschou SA, Buzzetti R, Mauricio D, De Leiva A et al.(2012). Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care
10.2337/dc12-0931
https://qmro.qmul.ac.uk/xmlui/handle/123456789/18410
Napoli N, Zardi E, Strollo R, Arigliani M, Daverio A, Olearo F, Tosi D, Dicuonzo G et al.(2012). Increased carotid thickness in subjects with recently-diagnosed diabetes from rural Cameroon. PLoS One vol. 7, (8)
10.1371/journal.pone.0041316
https://qmro.qmul.ac.uk/xmlui/handle/123456789/5339
VALORANI MG, Montelatici E, Germani A, Biddle A, D'Alessandro D, Strollo R, Patrizi MP, Lazzari L et al.(2012). Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potential. Cell Proliferation vol. 45, (3) 225-238.
10.1111/j.1365-2184.2012.00817
Pozzilli P(2011). Type 1 diabetes mellitus in 2011: Heterogeneity of T1DM raises questions for therapy. Nat Rev Endocrinol vol. 8, (2) 78-80.
10.1038/nrendo.2011.228
Buzzetti R, Cernea S, Petrone A, Capizzi M, Spoletini M, Zampetti S, Guglielmi C, Venditti C et al.(2011). C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study. Diabetes vol. 60, (11) 3067-3072.
10.2337/db10-0560
Park Y, Kim K, Pozzilli P(2011). Preface. Diabetes Metab Res Rev vol. 27, (8)
10.1002/dmrr.1301
Morviducci L, Di Flaviani A, Lauria A, Pitocco D, Pozzilli P, Suraci C, Frontoni S, CSII Study Group Of Lazio Region, Italy(2011). Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit. Diabetes Technol Ther vol. 13, (10) 1071-1074.
10.1089/dia.2011.0056
Pham MN, Kolb H, Mandrup-Poulsen T, Battelino T, Ludvigsson J, Pozzilli P, Roden M, Schloot NC et al. (2011). Adiponectin levels negatively associate with beta cell function in type 1 diabetes, in contrast to leptin and resistin. DIABETOLOGIA. vol. 54, S304-S304.
Di Stasio E, Maggi D, Berardesca E, Marulli GC, Bizzarri C, Lauria A, Portuesi R, Cavallo MG et al.(2011). Blue eyes as a risk factor for type 1 diabetes. Diabetes Metab Res Rev vol. 27, (6) 609-613.
10.1002/dmrr.1214
Palermo A, Napoli N, Maddaloni E, Lauria A, Manfrini S, Maurizi A, Altomare M, Leotta S et al. (2011). Buccal spray insulin: a new tool to treat subjects with impaired glucose tolerance. DIABETOLOGIA. vol. 54, S52-S52.
Tuccinardi D, Fioriti E, Manfrini S, D'Amico E, Pozzilli P(2011). DiaPep277 peptide therapy in the context of other immune intervention trials in type 1 diabetes. Expert Opin Biol Ther vol. 11, (9) 1233-1240.
10.1517/14712598.2011.599319
Pozzilli P, Schloot NC, Hosszufalusi N, Lauria A, Ludvigsson J, Mathieu C, Mauricio D, Rubinat E et al. (2011). Time dependent C-peptide decline in 4411 patients with recent onset type 1 diabetes followed for up to 10 years: a meta-analysis from 8 European centres. DIABETOLOGIA. vol. 54, S74-S74.
Napoli N, Pedone C, Pozzilli P, Lauretani F, Bandinelli S, Ferrucci L, Incalzi RA(2011). Effect of ghrelin on bone mass density: the InChianti study. Bone vol. 49, (2) 257-263.
10.1016/j.bone.2011.03.772
Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, Cavallo MG(2011). Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med vol. 9,
10.1186/1741-7015-9-85
Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum WA et al.(2011). Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4. Diabetologia vol. 54, (7) 1630-1638.
10.1007/s00125-011-2088-6
Vadacca M, Valorani MG, von Hofe E, Kallinteris NL, Buzzetti R, Pozzilli P(2011). Recognition of Ii-Key/MHC class II epitope hybrids derived from proinsulin and GAD peptides by T cells in type 1 diabetes. Horm Metab Res vol. 43, (7) 483-488.
10.1055/s-0031-1275705
Pozzilli P, Guglielmi C, Caprio S, Buzzetti R(2011). Obesity, autoimmunity, and double diabetes in youth. Diabetes Care vol. 34 Suppl 2, S166-S170.
10.2337/dc11-s213
Maurizi AR, Lauria A, Maggi D, Palermo A, Fioriti E, Manfrini S, Pozzilli P(2011). A Novel Insulin Unit Calculator for the Management of Type 1 Diabetes. DIABETES TECHNOL THE vol. 13, (4) 425-428.
10.1089/dia.2010.0190
Pedone C, Napoli N, Pozzilli P, Rossi FF, Lauretani F, Bandinelli S, Ferrucci L, Antonelli-Incalzi R(2011). Dietary pattern and bone density changes in elderly women: a longitudinal study. J Am Coll Nutr vol. 30, (2) 149-154.
10.1080/07315724.2011.10719954
Astorri E, Bombardi M, Peakman M, Pozzilli P, Pitzalis C (2011). EVOLUTION OF ECTOPIC LYMPHOID NEOGENESIS AND IN SITU AUTOANTIBODY PRODUCTION IN AUTOIMMUNE DIABETIC NOD MICE: CELLULAR AND MOLECULAR CHARACTERIZATION OF TERTIARY LYMPHOID STRUCTURES IN PANCREATIC ISLETS. RHEUMATOLOGY. vol. 50, 52-53.
Napoli N, Costanza F, Di Stasio E, Strollo R, Manfrini S, Cipponeri E, Picardi A, Carrano F et al.(2011). Blood glucose monitoring in the normal population: the PREDICA study. Acta Diabetol vol. 48, (1) 29-34.
10.1007/s00592-010-0212-6
Astorri E, Bombardieri M, Gabba S, Peakman M, Pozzilli P, Pitzalis C (2011). EVOLUTION OF ECTOPIC LYMPHOID NEOGENESIS AND IN SITU AUTOANTIBODIES PRODUCTION IN AUTOIMMUNE DIABETIC NOD MICE: CELLULAR AND MOLECULAR CHARACTERISATION OF TERTIARY LYMPHOID STRUCTURES IN PANCREATIC ISLETS. ANNALS OF THE RHEUMATIC DISEASES. vol. 70,
10.1136/ard.2010.148999.2
Pedone C, Napoli N, Pozzilli P, Lauretani F, Bandinelli S, Ferrucci L, Antonelli-Incalzi R(2011). Quality of diet and potential renal acid load as risk factors for reduced bone density in elderly women. Bone vol. 48, (2)
10.1016/j.bone.2010.09.004
Bonafini BA, Pozzilli P(2011). Body weight and beauty: the changing face of the ideal female body weight. Obes Rev vol. 12, (1) 62-65.
10.1111/j.1467-789X.2010.00754.x
Palermo A, Napoli N, Manfrini S, Lauria A, Strollo R, Pozzilli P(2011). Buccal spray insulin in subjects with impaired glucose tolerance: the prevoral study. Diabetes Obes Metab vol. 13, (1) 42-46.
10.1111/j.1463-1326.2010.01312.x
Pozzilli P, Guglielmi C, Maggi D, Carlone A, Buzzetti R, Manfrini S(2011). Clinical update on the use of immuno modulators (antiCD3, GAD, Diapep277, anti-IL1) in type 1 diabetes. Curr Pharm Des vol. 17, (29) 3224-3228.
10.2174/138161211798157531
POZZILLI P, STROLLO, R, NAPOLI, N(2010). Iatrogenic immunoendocrinopathy. Immunoendocrinology: Scientific and Clinical Aspects, Editors: Eisenbarth, GS, Humana Pr Inc
Napoli N, Pedone C, Pozzilli P, Lauretani F, Ferrucci L, Incalzi RA(2010). Adiponectin and bone mass density: The InCHIANTI study. Bone vol. 47, (6) 1001-1005.
10.1016/j.bone.2010.08.010
Astorri E, Guglielmi C, Bombardieri M, Alessandri C, Buzzetti R, Maggi D, Valesini G, Pitzalis C et al.(2010). Circulating Reg1α proteins and autoantibodies to Reg1α proteins as biomarkers of β-cell regeneration and damage in type 1 diabetes. Horm Metab Res vol. 42, (13) 955-960.
10.1055/s-0030-1267206
Astorri E, Bombardieri M, Gabba S, Peakman M, Pozzilli P, Pitzalis C (2010). Evolution of ectopic lymphoid neogenesis and in-situ autoantibodies production in autoimmune diabetic NOD mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islet. IMMUNOLOGY. vol. 131, 63-63.
Bizzarri C, Patera PI, Arnaldi C, Petrucci S, Bitti MLM, Scrocca R, Manfrini S, Portuesi R et al.(2010). Incidence of type 1 diabetes has doubled in Rome and the Lazio region in the 0- to 14-year age-group: a 6-year prospective study (2004-2009). Diabetes Care vol. 33, (11)
10.2337/dc10-1168
Astorri E, Bombardieri M, Gabba S, Peakman M, Pozzilli P, Pitzalis C(2010). Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets. J Immunol vol. 185, (6) 3359-3368.
10.4049/jimmunol.1001836
Maurizi A, Palermo A, Anguissola GB, Benevento D, Lauria A, Cipponeri H, Tuccinardi D, Manfrini S et al. (2010). A pocket instrument for calculating insulin need in the management of type 1 diabetes. DIABETOLOGIA. vol. 53,
Bruno G, Maule M, Merletti F, Novelli G, Falorni A, Iannilli A, Iughetti L, Altobelli E et al.(2010). Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI study. Diabetes vol. 59, (9) 2281-2287.
10.2337/db10-0151
Pozzilli P, Ghirlanda G, Brennan AM, Belanger B, Mckee CM (2010). Fasting and stimulated C-peptide at aseline in DEFEND-1, a phase 3 study of otelixizumab in new onset type 1 diabetes. DIABETOLOGIA. vol. 53, S189-S190.
Portuesi R, Bohm BO, Julier C, Pozzilli P (2010). HLA and insulin genes: Bayesian networks confirm interaction between the two most important susceptibility genes in type 1 diabetes in a French caucasian population. DIABETOLOGIA. vol. 53, S77-S78.
Bizzarri C, Pitocco D, Napoli N, Di Stasio E, Maggi D, Manfrini S, Suraci C, Cavallo MG et al.(2010). No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care vol. 33, (9) 1962-1963.
10.2337/dc10-0814
Napoli N, Bizzarri C, Pitocco D, Suraci C, Altomare M, Sacchetti E, Valente L, Pozzilli P (2010). Osteocalcin and its effect on metabolic control in type 1 diabetes. DIABETOLOGIA. vol. 53,
Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Seissler J et al. (2010). Proinflammatory and regulatory cytokines are similar in type 1 diabetes (T1D) and LADA and lower compared to type 2 diabetes (T2D) patients: results from Action LADA Study. DIABETOLOGIA. vol. 53, S184-S185.
Occhicone F, Quattrocchi CC, Napoli N, Dell'Aia P, D'Agostino F, Pozzilli P, Beomonte Zobel B(2010). Incidence of new fractures in women with osteoporosis-induced vertebral fractures detected on routine lateral chest radiographs. Radiol Med vol. 115, (5) 815-825.
10.1007/s11547-010-0564-6
Valorani MG, Germani A, Otto WR, Harper L, Biddle A, Khoo CP, Lin WR, Hawa MI et al.(2010). Hypoxia increases Sca-1/CD44 co-expression in murine mesenchymal stem cells and enhances their adipogenic differentiation potential. Cell Tissue Res vol. 341, (1) 111-120.
10.1007/s00441-010-0982-8
Bizzarri C, Pitocco D, Napoli N, Maggi D, Suraci C, Di Stasio E, Anguissola GB, Pozzilli P et al. (2010). A Double-Blind Trial with Calcitriol in Recent Onset Type 1 Diabetes (IMDIAB XIII). DIABETES. vol. 59, A88-A88.
Maurizi AR, Palermo A, Anguissola GB, Benevento D, Pantano AL, Cipponeri E, Tuccinardi D, Manfrini S et al. (2010). A Novel Insulin Unit Calculator for the Management of Type 1 Diabetes. DIABETES. vol. 59, A539-A539.
10.1089/dia.2010.0190
Zampetti S, Spoletini M, Petrone A, Capizzi M, Arpi ML, Tiberti C, Di Pietro S, Bosi E et al.(2010). Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5). Diabet Med vol. 27, (6) 701-704.
10.1111/j.1464-5491.2010.02997.x
Benevento D, Bizzarri C, Pitocco D, Crinò A, Moretti C, Spera S, Tubili C, Costanza F et al.(2010). Computer use, free time activities and metabolic control in patients with type 1 diabetes. Diabetes Res Clin Pract vol. 88, (3) e32-e34.
10.1016/j.diabres.2010.03.016
Khazrai YM, Cacciapaglia F, Sellaci T, Benevento D, Fioriti E, Manfrini S, Pozzilli P (2010). Dietary and Lifestyle Differences between an Urban and a Rural Population in Central Italy. DIABETES. vol. 59, A679-A679.
Maggi D, Camera E, Abril E, Picardo M, Maurizi AR, Manfrini S, Pozzilli P (2010). Effects of a Loofa Scrub Soap Prepared from Dead Sea for Care of Diabetic Foot. DIABETES. vol. 59, A628-A629.
Khazrai YM, Cacciapaglia F, Manfrini S, Bodoni G, Gillanti G, Lorubbio A, Leto G, Buzzetti R et al. (2010). Empowering People with Diabetes Is a Key for Optimal Disease Management. DIABETES. vol. 59, A602-A602.
Spoletini M, Maggi D, Zampetti S, Astorri E, Buzzetti R, Pozzilli P, Imdiab Grp (2010). OCA2 Gene Polymorphisms Are Associated with Specific Eye Colour and Skin Phenotype in Type 1 Diabetes. DIABETES. vol. 59, A330-A331.
Napoli N, Zardi E, Strollo R, Arigliani M, Guglielmi C, Tosi D, Daverio A, Scarpa F et al. (2010). The Effect of a Dietary Education Program in a Diabetic Population from Sub-Saharian Africa. DIABETES. vol. 59, A275-A275.
Napoli N, Strollo R, Pozzilli P (2010). CALCITIOL ADMINISTRATION IN TYPE 1 DIABETIC ADOLESCENTS: DOES IT IMPROVE OR IMPAIR BONE HEALTH?. OSTEOPOROSIS INTERNATIONAL. vol. 21, 309-309.
Pozzilli P, Leslie RD, Chan J, De Fronzo R, Monnier L, Raz I, Del Prato S(2010). The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach. Diabetes Metab Res Rev vol. 26, (4) 239-244.
10.1002/dmrr.1092
Cardwell CR, Stene LC, Joner G, Davis EA, Cinek O, Rosenbauer J, Ludvigsson J, Castell C et al.(2010). Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data. Diabetologia vol. 53, (4) 641-651.
10.1007/s00125-009-1648-5
Pedone C, Napoli N, Pozzilli P, Lauretani F, Bandinelli S, Ferrucci L, Antonelli-Incalzi R(2010). Quality of diet and potential renal acid load as risk factors for reduced bone density in elderly women. Bone vol. 46, (4) 1063-1067.
10.1016/j.bone.2009.11.031
Napoli N, Strollo R, Tosi D, Daverio A, Arigliani M, Mottini G, Pozzilli P(2010). The effect of dietary education on metabolic control and vascular impairment in a diabetic population from sub-saharian Africa. ENDOCR J vol. 57, S358-S359.
Cardwell CR, Stene LC, Joner G, Bulsara MK, Cinek O, Rosenbauer J, Ludvigsson J, Jané M et al.(2010). Maternal age at birth and childhood type 1 diabetes: a pooled analysis of 30 observational studies. Diabetes vol. 59, (2) 486-494.
10.2337/db09-1166
Pozzilli P, Raskin P, Parkin CG(2010). Review of clinical trials: update on oral insulin spray formulation. Diabetes Obes Metab vol. 12, (2) 91-96.
10.1111/j.1463-1326.2009.01127.x
Pozzilli P(2010). NEW CURATIVE TREATMENT FOR TYPE 1 DIABETES. CHILD CARE HLTH DEV vol. 36, 14-14.
Napoli N, Mottini G, Arigliani M, Creta A, Giua R, Incammisa A, Carotti S, Sihom F et al.(2010). Unexpectedly high rates of obesity and dysglycemia among villagers in Cameroon. Diabetes Metab Res Rev vol. 26, (1) 10-12.
10.1002/dmrr.1036
Pozzilli P, Strollo R, Barchetta I(2009). Natural history and immunopathogenesis of type 1 diabetes. Endocrinol Nutr vol. 56S4, 50-52.
10.1016/S1575-0922(09)73519-3
Cernea S, Buzzetti R, Pozzilli P (2009). Beta-cell protection and therapy for latent autoimmune diabetes in adults. Diabetes Care. vol. 32 Suppl 2, S246-S252.
10.2337/dc09-S317
Cernea S, Raz I, Herold KC, Hirshberg B, Roep BO, Schatz DA, Fleming GA, Pozzilli P et al.(2009). Challenges in developing endpoints for type 1 diabetes intervention studies. Diabetes Metab Res Rev vol. 25, (8) 694-704.
10.1002/dmrr.1002
Barchetta I, Cavallo MG, Angelico F, Del Ben M, Fraioli A, Morini S, Pozzilli P (2009). HYPOVITAMINOSIS D IS ASSOCIATED WITH MILD NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC SYNDROME'S COMPONENTS IN DYS-METABOLIC ADULT PATIENTS. HEPATOLOGY. vol. 50, 797A-797A.
Buzzetti R, Cernea S, Petrone A, Spoletini M, Zampetti S, Guglielmi C, Venditti C, Pozzilli P (2009). C-Peptide response and HLA genotypes in subjects with recent onset type 1 diabetes following immunotherapy with diapep277. DIABETOLOGIA. vol. 52, S192-S193.
Napoli N, Pitocco D, Di Stasio E, Bizzarri C, Maggi D, Strollo R, Barchetta I, Suraci C et al. (2009). Calcitriol administration in the youth reduces bone turnover and may prevent bone loss in type 1 diabetes. DIABETOLOGIA. vol. 52, S347-S347.
Di Gialleonardo V, de Vries EFJ, Chianelli M, Wolffenbuttel BHR, De Vos P, Pozzilli P, Dierckx RA, Signore A (2009). F-18-Interleukin-2, a novel radioactive probe for insulitis imaging by PET. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. vol. 36, S211-S211.
Palermo A, Napoli N, Costanza F, Beretta G, Manfrini S, Pozzilli P (2009). Management of impaired glucose tolerance using buccal spray insulin. DIABETOLOGIA. vol. 52, S373-S373.
Fallucca F, Pozzilli P(2009). Physical exercise, public health and quality of life in diabetes. Diabetes Metab Res Rev vol. 25 Suppl 1, S1-S3.
10.1002/dmrr.990
Pronina E, Guglielmi C, Petraikina H, Antsiferov M, Duchareva O, Pozzilli P (2009). Rapid GlucoseSpray: an innovative tool to control hypoglycaemia and improve HbA(1c) in children with type 1 diabetes. DIABETOLOGIA. vol. 52, S346-S346.
Pozzilli P, Spoletini M, Zampetti S, Capizzi M, Kyanvash S, Venditti C, Buzzetti R, IMDIAB Grp (2009). Similar frequencies of HLA risk genotypes in type 1 diabetes over the past six decades in a southern European Caucasian population. DIABETOLOGIA. vol. 52, S120-S120.
Beyan H, Buckley LR, Bustin SA, Yousaf N, Pozzilli P, Leslie RD(2009). Altered monocyte cyclo-oxygenase response in non-obese diabetic mice. Clin Exp Immunol vol. 155, (2) 304-310.
10.1111/j.1365-2249.2008.03825.x
Khoo CP, Valorani MG, Brittan M, Alison MR, Warnes G, Johansson U, Hawa M, Pozzilli P(2009). Characterization of endothelial progenitor cells in the NOD mouse as a source for cell therapies. Diabetes Metab Res Rev vol. 25, (1) 89-93.
10.1002/dmrr.898
Pozzilli P, Guglielmi C(2009). Double diabetes: a mixture of type 1 and type 2 diabetes in youth. Endocr Dev vol. 14, 151-166.
10.1159/000207484
Hawa MI, Thivolet C, Mauricio D, Alemanno I, Cipponeri E, Collier D, Hunter S, Buzzetti R et al.(2009). Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care vol. 32, (1) 160-164.
10.2337/dc08-1419
https://qmro.qmul.ac.uk/xmlui/handle/123456789/19764
Khoo CP, Pozzilli P, Alison MR(2008). Endothelial progenitor cells and their potential therapeutic applications. Regen Med vol. 3, (6) 863-876.
10.2217/17460751.3.6.863
Picardi A, Cipponeri E, Bizzarri C, Fallucca S, Guglielmi C, Pozzilli P(2008). Menarche in type 1 diabetes is still delayed despite good metabolic control. Fertil Steril vol. 90, (5) 1875-1877.
10.1016/j.fertnstert.2007.09.035
Cernea S, Pozzilli P(2008). New potential treatments for protection of pancreatic B-cell function in Type 1 diabetes. Diabet Med vol. 25, (11) 1259-1267.
10.1111/j.1464-5491.2008.02556.x
Leslie RDG, Kolb H, Schloot NC, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Sarti C et al.(2008). Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev vol. 24, (7) 511-519.
10.1002/dmrr.877
Greenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM et al.(2008). Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care vol. 31, (10) 1966-1971.
10.2337/dc07-2451
Brophy S, Yderstraede K, Mauricio D, Hunter S, Hawa M, Pozzilli P, Schernthaner G, Schloot N et al.(2008). on behalf of the Action LADA Group: Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. (vol 31, pg 439, 2008). DIABETES CARE vol. 31, (10) 2077-2077.
Guglielmi C, Astorri E, Portuesi R, Bombardieri M, Valorani M, Pozzilli P(2008). A diet rich in protein and poor in starch with reduced food intake prevents diabetes in the NOD moose: the significance of Reg gene expression in the pancreas. DIABETOLOGIA vol. 51, S229-S229.
Astorri E, Bombardieri M, Guglielmi C, Pitzalis C, Pozzilli P(2008). Beta cell regeneration in type 1 diabetes: the role of Reg genes in NOD mice. DIABETOLOGIA vol. 51, S186-S186.
Bizzarri C, Benevento D, Pitocco D, Crino A, Spera S, Tubili C, Costanza F, Maurizi A et al.(2008). Free time activities and blood glucose control in patients with type 1 diabetes. DIABETOLOGIA vol. 51, S419-S419.
Pronina E, Petraikina H, Antsiferov M, Duchareva O, Guglielmi C, Khazrai M, Pozzilli P (2008). Glucose RapidSpray (TM) for a new management of hypoglycaemia in children up to 5 years of age with type 1 diabetes. DIABETOLOGIA. vol. 51, S383-S383.
Khoo CP, Hill N, Valorani MG, Signore A, Pozzilli P(2008). Intracellular inhibition of JNK kinase reduces lymphocyte homing into endocrine pancreas of non obese diabetic (NOD) mouse. DIABETOLOGIA vol. 51, S228-S229.
Schloot NC, Hawa MI, Scherbaum WA, Pozzilli P, Leslie R, Seissler J, Action LADA Consortium(2008). Organ specific autoantibodies in patients with type 1 diabetes, LADA and type 2 diabetes. DIABETOLOGIA vol. 51, S235-S235.
Petrone A, Park Y, Genovese S, Woo JT, Giordano C, Lee KW, Pontiroli AE, Paik SH et al.(2008). Similarities and differences between Caucasian and Asian LADA. DIABETOLOGIA vol. 51, S155-S156.
Cernea S, Moretti C, Tubili C, Suraci C, Pitocco D, Barchetta I, Manfrini S, Napoli N et al.(2008). The natural history of residual beta cell function in patients with type 1 diabetes under continuous subcutaneous insulin infusion therapy. DIABETOLOGIA vol. 51, S397-S397.
Hawa MI, Cipponeri E, Collier D, Loh Y, Pozzilli P, Brophy S, Hunter S, Thivolet C et al.(2008). The prevalence of metabolic syndrome is much less in LADA and type 1 diabetes than type 2 diabetes: ACTION LADA 3. DIABETOLOGIA vol. 51, S155-S155.
Pronina EA, Petraikina EE, Antsiferov MB, Duchareva OV, Petrone A, Buzzetti R, Pozzilli P(2008). A 10-year (1996-2005) prospective study of the incidence of Type 1 diabetes in Moscow in the age group 0-14 years. Diabet Med vol. 25, (8) 956-959.
10.1111/j.1464-5491.2008.02508.x
Cavallo MG, Pozzilli P, Misiti S, Baroni MG(2008). Insulinoma CM cell line as in vitro model for beta-cell. J Cell Physiol vol. 216, (2)
10.1002/jcp.21409
Cacciapaglia F, Arcarese L, Rigon A, Vadacca M, Valorani MG, Pozzilli P, Afeltra A(2008). Antinuclear antibodies prevalence in Filipinos migrated to Italy. Eur Rev Med Pharmacol Sci vol. 12, (4) 267-270.
Gentilucci UV, Picardi A, Manfrini S, Khazrai YM, Fioriti E, Altomare M, Guglielmi C, Di Stasio E et al.(2008). Westernization of the Filipino population resident in Rome: obesity, diabetes and hypertension. Diabetes Metab Res Rev vol. 24, (5) 364-370.
10.1002/dmrr.807
Vadacca M, Valorani MG, Humphreys R, Kallinteris N, Valente L, Pozzilli P (2008). Detection of T cell response to insulin and GAD in Type 1 diabetes using the Ii-Key-hybrid technique. DIABETES. vol. 57, A18-A18.
Guglielmi C, Astorri E, Bizzarri C, Suraci C, Pitocco D, Morviducci L, Buzzetti R, Pozzilli P et al. (2008). High prevalence of double diabetes in a Caucasian population. DIABETES. vol. 57, A273-A274.
Picardi A, Costanza F, Di Stasio E, Napoli N, Carrano F, Dell'Anna V, Macin W, Pozzilli P (2008). The PREDICA study (PREdiction of diabetes from CApillary Blood Glucose) in the general population. DIABETES. vol. 57, A674-A675.
Petrone A, Spoletini M, Zampetti S, Capizzi M, Zavarella S, Osborn J, Pozzilli P, Buzzetti R et al.(2008). The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control. Diabetes Care vol. 31, (6) 1214-1218.
10.2337/dc07-1158
Khazrai M, Cacciapaglia F, Picardi A, Anguissola GB, Guglielmi C, Manfrini S, Pozzilli P (2008). Treatment of symptoms of neuroglycopenia with Glucose Rapid-Spray (TM) to avoid rebound hyperglycaemia. DIABETES. vol. 57, A564-A564.
Cardwell CR, Stene LC, Joner G, Cinek O, Svensson J, Goldacre MJ, Parslow RC, Pozzilli P et al.(2008). Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia vol. 51, (5) 726-735.
10.1007/s00125-008-0941-z
Noble JA, Martin A, Valdes AM, Lane JA, Galgani A, Petrone A, Lorini R, Pozzilli P et al.(2008). Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls. Hum Immunol vol. 69, (4-5) 291-300.
10.1016/j.humimm.2008.02.003
Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C, Cossu E, Pozzilli P et al.(2008). The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. Diabetes Care vol. 31, (3) 534-538.
10.2337/dc07-1457
Brophy S, Yderstraede K, Mauricio D, Hunter S, Hawa M, Pozzilli P, Schernthaner G, Schloot N et al.(2008). Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diabetes Care vol. 31, (3) 439-441.
10.2337/dc07-1308
Chianelli M, Parisella MG, Visalli N, Mather SJ, D'Alessandria C, Pozzilli P, Signore A, IMDIAB study group(2008). Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy. Diabetes Metab Res Rev vol. 24, (2) 115-122.
10.1002/dmrr.767
Pitocco D, DiStasio E, Crinò A, Manfrini S, Guglielmi C, Visalli N, Suraci C, Matteoli MC et al.(2008). Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function. Horm Metab Res vol. 40, (1) 66-68.
10.1055/s-2007-993217
Merriman T, Twells R, Merriman M, Eaves I, Cox R, Cucca F, McKinney P, Shield J et al.(2007). Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21 (vol 6, pg 1003, 1997). HUM MOL GENET vol. 16, (24) 3197-3197.
10.1093/hmg/ddm307
Pozzilli P, Guglielmi C, Pronina E, Petraikina E(2007). Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youths. Pediatr Diabetes vol. 8 Suppl 9, 88-95.
10.1111/j.1399-5448.2007.00338.x
Spoletini M, Petrone A, Zampetti S, Capizzi M, Zavarella S, Osborn J, Foffi C, Tuccinardi D et al.(2007). Low-risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis. Diabet Med vol. 24, (12) 1487-1490.
10.1111/j.1464-5491.2007.02292.x
Guglielmi C, Battistoni F, Valente L, Astorri E, Valorani MG, Pitocco D, Pozzilli P, IMDIAB Grp(2007). Circulating Reg1-alpha plasma levels as potential marker of beta cell regeneration in type 1 diabetes. ACTA DIABETOL vol. 44, S18-S19.
Vadacca M, Valorani G, Humphreys R, Kallinteris N, Valente L, D'Agostino G, Pozzilli P, IMDIAB Grp (2007). Ii-key/MHC class II epitope hybrid technology to detect T cell response to insulin and GAD in type 1 diabetes. DIABETOLOGIA. vol. 50, S30-S30.
Khoo CP, Valorani MG, Brittan M, Alison MR, Guglielmi C, Warnes G, Johansson U, Hawa MI et al. (2007). Isolation, characterisation and prospects of endothelial progenitor cells to aid pancreatic beta cell regeneration. DIABETOLOGIA. vol. 50, S221-S222.
Brunetti P, Muggeo M, Cattin L, Arcangeli A, Pozzilli P, Provenzano V, Francesconi A, Calatola P et al. (2007). Italian experience trial for the implementation of insulin glargine in basal-bolus regimen in patients with type 1 diabetes. DIABETOLOGIA. vol. 50, S394-S394.
Spoletini M, Petrone A, Capizzi M, Zavarella S, Zampetti S, Leto G, Alemanno I, Pozzilli P et al. (2007). Low risk HLA genotype is associated with less destruction of beta cells persisting 12 months after diagnosis. DIABETOLOGIA. vol. 50, S133-S133.
Petrone A, Spoletini M, Capizzi M, Zampetti S, Zavarella S, Venditti C, Foffi C, Alemanno I et al. (2007). The PTPN22 1858T gene variant is associated with reduced residual insulin secretion and worst metabolic control in type 1 diabetes. DIABETOLOGIA. vol. 50, S113-S113.
Locatelli M, Buzzetti R, Galgani A, Montemari AL, Khazrai M, Petrone A, Visalli N, Meschi F et al.(2007). Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3). Diabet Med vol. 24, (8) 916-919.
10.1111/j.1464-5491.2007.02192.x
Maggi D, Berardesca E, Marulli G, Manfrini S, Bizzarri C, Lauria A, Pitocco D, Pozzilli P (2007). Blue eyes and fair skin are risk factors for type 1 diabetes in the Mediterranean region. DIABETES. vol. 56, A267-A267.
Khazrai YM, Manfrini S, Cacciapaglia F, Spallina F, Picardi A, Spera S, Benevento D, Pozzilli P (2007). Effectiveness of group medical nutrition therapy in lowering HbA(1c) in type 2 diabetes. DIABETES. vol. 56, A41-A41.
Picardi A, Merola YM, Altomare M, Visalli N, Cipponeri E, Pozzilli P (2007). Glucose rapidspray, a new tool to control progression towards hypoglycaemia. DIABETES. vol. 56, A128-A128.
Napoli N, Arigliani M, Creta A, Giua R, Incam-Misa A, Mottini G, Carotti C, Sihom F et al. (2007). High prevalence of diabetes, impaired glucose tolerance and increased body weight in a rural population of sub-Saharian Africa despite lack of known risk factors. DIABETES. vol. 56, A632-A632.
Brunetti P, Muggeo M, Cattin L, Arcangeli A, Pozzilli P, Provenzano V, Francesconi A, Calatola P et al. (2007). Italian experience trial for the implementation of LANTUS in basal-bolus regimen in patients with type 1 diabetes. DIABETES. vol. 56, A558-A558.
Guglielmi C, Battistoni F, Valente L, Astorri E, Valorani MG, Pozzilli P, Imdiab G (2007). Raised levels of reg1-alpha in sera of subjects with type I diabetes: Evidence for beta cell regeneration. DIABETES. vol. 56, A323-A323.
Khazrai YM, Altomare M, Visalli N, Cipolloni L, Maurizi AM, Pozzilli P (2007). Reduction of body weight through diet and the use of glucose rapidspray. DIABETES. vol. 56, A463-A463.
Pozzilli P(2007). Immuno-intervention and preservation of beta-cell function in type 1 diabetes. Diabetes Metab Res Rev vol. 23, (4) 255-256.
10.1002/dmrr.746
Pozzilli P, Buzzetti R(2007). A new expression of diabetes: double diabetes. Trends Endocrinol Metab vol. 18, (2) 52-57.
10.1016/j.tem.2006.12.003
Picardi A, Valorani MG, Vespasiani Gentilucci U, Manfrini S, Ciofini O, Cappa M, Guglielmi C, Pozzilli P et al.(2007). Raised C-reactive protein levels in patients with recent onset type 1 diabetes. Diabetes Metab Res Rev vol. 23, (3) 211-214.
10.1002/dmrr.671
Pitocco D, Pozzilli P, IMDIAB Grp(2007). The effects of calcitriol and nicotinamide on residual pancreatic beta-cell funtion in patients with recent-onset Type 1 diabetes (IMDIAB XI) - Response. DIABETIC MED vol. 24, (2) 219-220.
Papavramidou N, Christopoulou-Aletra H, Pozzilli P(2007). Endocrinology and art. J ENDOCRINOL INVEST vol. 30, (1) 83-83.
10.1007/BF03347401
Christopoulou-Aletra H, Papavramidou N, Pozzilli P(2007). Goitrous beauty in Artemisia Gentileschi's Judith and her Maidservant. Thyroid vol. 17, (1) 37-38.
10.1089/thy.2006.0223
Gentilucci UV, Picardi A, Pozzilli P(2006). Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis: response to Lecube et al. Diabetes Care vol. 29, (11) 2558-2559.
10.2337/dc06-1374
Pozzilli P, Guglielmi C (2006). Immunomodulation for the prevention of SPIDDM and LADA. Ann N Y Acad Sci. vol. 1079, 90-98.
10.1196/annals.1375.012
Picardi A, Visalli N, Lauria A, Suraci C, Buzzetti R, Merola MK, Manfrini S, Guglielmi C et al.(2006). Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes. Horm Metab Res vol. 38, (10) 668-672.
10.1055/s-2006-954586
Manfrini S, Bruni R, Terminio N, Khazrai M, Sandri G, Benevento D, Spera S, Ganz M et al. (2006). Alexithymia in type 1 diabetes and coeliac disease. DIABETOLOGIA. vol. 49, 531-532.
Vadacca M, Valorani G, Humphreys RE, Kallinteris N, Valente L, Pozzilli P, Group I (2006). Ii-key/MHC class II epitope hybrid technology and ELISPOT as say in type 1 diabetes. DIABETOLOGIA. vol. 49, 165-166.
Spoletini M, Petrone A, Zampetti S, Alemanno I, Capizzi M, Zavarella S, Bizzarri C, Pozzilli P et al. (2006). Preservation of beta cell secretion in T1DM subjects with low risk HLA genotype. DIABETOLOGIA. vol. 49, 444-445.
Mandrup-Poulsen TR, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lalic NM, Martinez-Larrad MT, Mauricio D et al. (2006). The European C-Peptide Trial CPT: comparison of liquid mixed meal and glucagon stimulation assays for the analysis of residual beta cell function in type 1 diabetes. DIABETOLOGIA. vol. 49, 375-376.
Petrone A, Capizzi M, Giaccari A, Bosi E, Cucinotta D, Cossu E, Suraci C, Falorni A et al. (2006). The Protein Tyrosine Phosphatase Non receptor (PTPN22) is associated with high GAD antibody titre in adult-onset autoimmune diabetes (The NIRAD Study). DIABETOLOGIA. vol. 49, 183-184.
Prisco F, Picardi A, Iafusco D, Lorini R, Minicucci L, Martinucci ME, Toni S, Cerutti F et al.(2006). Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study). Pediatr Diabetes vol. 7, (4) 223-228.
10.1111/j.1399-5448.2006.00187.x
Bessaoud K, Boudraa G, de Ropolo MM, de Sereday M, Marti ML, Moser M, Lapertosa S, Damiano M et al.(2006). Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. DIABETIC MED vol. 23, (8) 857-866.
10.1111/j.1464-5491.2006.01925.x
Christopoulou-Aletra H, Papavramidou N, Pozzilli P(2006). Obesity in the Neolithic era: a Greek female figurine. Obes Surg vol. 16, (8) 1112-1114.
10.1381/096089206778026334
Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola GB, Visalli N et al.(2006). The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet Med vol. 23, (8) 920-923.
10.1111/j.1464-5491.2006.01921.x
Pozzilli P, Astorri E, Bizzari C, Cappa M, De Rossi G, Leslie RDG, Hawa M, Spoletini ML et al. (2006). GAD, IA2 and insulin autoantibodies in children diagnosed with acute lymphoblastic leukaemia: Relevance for type 1 diabetes. DIABETES. vol. 55, A412-A412.
Vadacca M, Valeri C, Gigante A, Guglielmi C, Pozzilli P, Action LADA Grp (2006). Gender differences and the metabolic syndrome in patients with type 2 diabetes with or without auioantibodies to glutamic acid decarboxilase (GAD). DIABETES. vol. 55, A283-A283.
Vadacca M, Humphreys RE, Kallinteris NL, Valente L, Valorani G, Pozzilli P, IMDIAB Grp (2006). Ii-key/insulin MHC class-II antigenic epitope peptides in type 1 diabetes. DIABETES. vol. 55, A88-A88.
Yeganeh MK, Cacciapaglia F, Beretta G, Altomare M, Cherubini V, Suraci C, Pozzilli P, Trigr Study Grp (2006). Pregnancy and offspring outcomes in families with one parent affected by type 1 diabetes. DIABETES. vol. 55, A607-A607.
Pozzilli P, Palermo A, Manfrini S, Fioriti E, Visalli N, Suraci C, Picardi A, IMDIAB Grp (2006). Prevalence of the metabolic syndrome in type 1 diabetes. DIABETES. vol. 55, A233-A233.
Leslie RDG, Williams R, Pozzilli P(2006). Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. J Clin Endocrinol Metab vol. 91, (5) 1654-1659.
10.1210/jc.2005-1623
Ou D, Wang X, Metzger DL, Ao Z, Pozzilli P, James RFL, Chen L, Warnock GL(2006). Suppression of Human T-Cell Responses to β-Cells by Activation of B7-H4 Pathway. Cell Transplant vol. 15, (5) 399-410.
10.3727/000000006783981837
Genovese S, Bazzigaluppi E, Gonçalves D, Ciucci A, Cavallo MG, Purrello F, Anello M, Rotella CM et al.(2006). Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. Eur J Endocrinol vol. 154, (3) 441-447.
10.1530/eje.1.02115
Hawa MI, Picardi A, Costanza F, D'Avola D, Beretta Anguissola G, Guglielmi C, Mottini G, Fezeu L et al.(2006). Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon. Clin Immunol vol. 118, (2-3) 229-232.
10.1016/j.clim.2005.09.016
Pozzilli P(2006). Prevention of diabetes in children. HORM RES vol. 65, 9-9.
Ou D, Wang X, Metzger DL, Ao Z, Pozzilli P, James RFL, Chen L, Warnock GL(2006). Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway. Cell Transplant vol. 15, (5) 399-410.
10.3727/000000006783981837
Pozzilli P, Manfrini S, Crinò A, Picardi A, Leomanni C, Cherubini V, Valente L, Khazrai M et al.(2005). Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res vol. 37, (11) 680-683.
10.1055/s-2005-870578
Crinó A, Schiaffini R, Ciampalini P, Suraci MC, Manfrini S, Visalli N, Matteoli MC, Patera P et al.(2005). A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus. J Pediatr Endocrinol Metab vol. 18, (8) 749-754.
10.1515/jpem.2005.18.8.749
Pozzilli P, Manfrini S, Costanza F, Coppolino G, Cavallo MG, Fioriti E, Modi P(2005). Biokinetics of buccal spray insulin in patients with type 1 diabetes. Metabolism vol. 54, (7) 930-934.
10.1016/j.metabol.2005.02.008
Ou D, Wang X, Metzger DL, Robbins M, Huang J, Jobin C, Chantler JK, James RFL et al.(2005). Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB. Hum Immunol vol. 66, (7) 799-809.
10.1016/j.humimm.2005.03.009
Pozzilli P, Manfrini S, Buzzetti R, Lampeter E, Leeuw ID, Iafusco D, Prisco M, Ionescu-Tirgoviste C et al.(2005). Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study. Diabetes Res Clin Pract vol. 68, (3) 258-264.
10.1016/j.diabres.2004.10.001
Petrone A, Galgani A, Spoletini M, Alemanno I, Di Cola S, Bassotti G, Picardi A, Manfrini S et al.(2005). Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype. Diabetes Metab Res Rev vol. 21, (3) 271-275.
10.1002/dmrr.549
Ou D, Wang X, Metzger DL, James RFL, Pozzilli P, Plesner A, Korneluk RG, Verchere CB et al.(2005). Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis. Hum Immunol vol. 66, (3) 274-284.
10.1016/j.humimm.2004.12.002
Pozzilli P, Khazrai YM(2005). "La Monstrua Vestida", a case of Prader-Willi syndrome. J Endocrinol Invest vol. 28, (2)
10.1007/bf03345368
Vadacca M, Valorani MG, Valente L, Humpreys RE, Pozzilli P (2005). A novel approach to study T cell response to Ii-KEY/MHC class II epitope hybrid peptides in type 1 diabetes. DIABETOLOGIA. vol. 48, A99-A99.
Manfrini S, Bruni R, Terminio N, Poterzio F, Ricci S, Sforza S, Pantano AL, Costanza E et al. (2005). Alexithymia in subjects with type 1 diabetes. DIABETOLOGIA. vol. 48, A323-A324.
Ou D, Wang X, Metzger DL, Ao Z, Pozzilli P, Chen L, Warnock GL (2005). B7-H4.Ig inhibits human beta-cell destruction mediated by beta cell-specific cytotoxic T cells derived from patients with type 1 diabetes. DIABETES. vol. 54, A311-A311.
POZZILLI P, Warnock G, Ou D, Chen L, Ao Z, Metzger DL, Wang X, James RFL(2005). Induction of human T-cell tolerance to B cells by activation of B7-H4 pathway. Human Immunology
Spoletini M, Petrone A, Galgani A, Bassotti G, Guglielmi C, Picardi A, Manfrini S, Imdiab G et al. (2005). Insulin secretion at diagnosis of type 1 diabetes is associated with both age of onset and HLA class II. DIABETOLOGIA. vol. 48, A115-A116.
Locatelli M, Buzzetti R, Galgani A, Montemari A, Lorini R, Meschi F, Bottazzo G, Pozzilli P (2005). Investigation of risk factors associated with different HLA genotypes of susceptibility to type 1 diabetes. DIABETES. vol. 54, A276-A277.
Valiante S, Barchetta I, Calabria M, Leomanni C, Manfrini S, Hawa M, Leslie D, Pozzilli P et al. (2005). Prevalence of GAD antibodies in diabetic patients with or without the metabolic syndrome. DIABETES. vol. 54, A310-A310.
Picardi A, Valorani MG, Cio-Fini O, Manfrini S, D'Avola D, Valente L, Cappa M, Pozzilli P et al. (2005). Raised C-reactive protein in recent onset type 1 diabetes. DIABETES. vol. 54, A176-A176.
Lorini R, Minicucci L, Napoli F, Padovani P, Bazzigaluppi E, Tortoioli C, Cherubini V, Bottazzo G et al.(2005). Screening for type 1 diabetes genetic risk in newborns of continental Italy. Primary prevention (Prevefin Italy)--preliminary data. Acta Biomed vol. 76 Suppl 3, 31-35.
Carle F, Gesuita R, Bruno G, Coppa GV, Falorni A, Lorini R, Martinucci ME, Pozzilli P et al.(2004). Diabetes incidence in 0- to 14-year age-group in Italy: a 10-year prospective study. Diabetes Care vol. 27, (12) 2790-2796.
10.2337/diacare.27.12.2790
Valeri C, Pozzilli P, Leslie D(2004). Glucose control in diabetes. Diabetes Metab Res Rev vol. 20 Suppl 2, S1-S8.
10.1002/dmrr.512
Monetini L, Cavallo MG, Sarugeri E, Sentinelli F, Stefanini L, Bosi E, Thorpe R, Pozzilli P et al.(2004). Cytokine profile and insulin antibody IgG subclasses in patients with recent onset type 1 diabetes treated with oral insulin. Diabetologia vol. 47, (10) 1795-1802.
10.1007/s00125-004-1521-5
Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S et al.(2004). A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes (vol 36, pg 837, 2004). NAT GENET vol. 36, (9) 1024-1024.
10.1038/ng0904-1024b
Hawa MI, Valorani MG, Buckley LR, Beales PE, Afeltra A, Cacciapaglia F, Leslie RD, Pozzilli P(2004). Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse. Horm Metab Res vol. 36, (9) 620-624.
10.1055/s-2004-825926
Valorani MG, Hawa MI, Buckley LR, Afeltra A, Cacciapaglia F, Pozzilli P(2004). The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implications for trials of diabetes prevention in humans. Diabetes Metab Res Rev vol. 20, (5) 394-398.
10.1002/dmrr.463
Veitenhansl M, Stegner K, Hierl F-X, Dieterle C, Feldmeier H, Gutt B, Landgraf R, Garrow AP et al.(2004). 40th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004. Diabetologia vol. 47, (Suppl 1) A1-A464.
10.1007/BF03375463
Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S et al.(2004). A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet vol. 36, (8) 837-841.
10.1038/ng1391
Beyan H, Valorani GM, Imdiab G, Pozzilli P, Leslie RDG (2004). Abnormalities in plasma 1,25-dihydroxyvitamin D3, and cellular 1-alpha hydroxylase and Cyclooxygenase-2 mRNA levels in recent-onset type 1 diabetes. DIABETOLOGIA. vol. 47, A188-A188.
Ola TO, Hawa MI, Beck-Nielsen H, Buzzetti R, Scherbaum W, Kolb H, Tuomilehto J, Thivolet C et al. (2004). Action LADA a multinational European project in latent autoimmune diabetes in adults. DIABETOLOGIA. vol. 47, A113-A113.
Pozzilli P, Pitocco D, Visalli N, Spera S, Corbi S, Suraci C, Crino A, Patera P et al. (2004). C-peptide and HbA1c levels at diagnosis indicate a different pathogenic process depending on the age at onset of Type 1 diabetes. DIABETOLOGIA. vol. 47, A299-A299.
Pitocco D, Visalli N, Crino A, Costantino F, Manfrini S, Spera S, Suraci C, Patera P et al. (2004). Calcitriol versus nicotinamide in patients with recent onset Type 1 diabetes: IMDIAB XI randomised trial. DIABETOLOGIA. vol. 47, A185-A186.
Anguissola GB, Totonelli A, D'Avola D, Longhitano S, Costanza F, Fioriti E, Agro F, Pozzilli P (2004). Continuous glucose monitoring for the evaluation of peri-operative stress in patients with Type 2 diabetes, impaired glucose tollerance and normal subjects. DIABETOLOGIA. vol. 47, A309-A309.
Guglielmi C, Galgani A, Anguissola GB, D'Avola D, Pozzilli P (2004). Different HLA pattern in patients affected by LADA in Congo, central Africa. DIABETOLOGIA. vol. 47, A130-A130.
Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS et al.(2004). C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop (vol 53, pg 250, 2004). DIABETES vol. 53, (7) 1934-1934.
Pozzilli P, Visalli N, Picardi A, Manfrini S, Crino A, Suraci C, Pitocco D, Ghirlanda G et al. (2004). C-peptide and HbA1c levels at diagnosis indicate a different pathogenic process depending on the age of onset of type 1 diabetes. DIABETES. vol. 53, A603-A603.
Ou DW, Wang XJ, Metzger DL, James RFL, Pozzilli P, Plesner A, Korneluk RG, Verchere CB et al. (2004). Cytoprotection of pancreatic beta cells by co-overexpression of Bcl-2 and XIAP genes blocking TRAIL-mediated death-signal transduction pathways. DIABETES. vol. 53, A444-A444.
Gugielmi C, Galgani A, Beretta G, Davola D, Tshilolo L, Mottini G, Caro A, Spoletini M et al. (2004). Different HLA pattern in patients affected by LADA in Congo, central Africa. DIABETES. vol. 53, A536-A536.
Noble JA, Valdes AM, McGrue Q, Martin A, Galgani A, Di Cola S, Petrone A, Erlich HA et al. (2004). Genetics of type 1 diabetes in Italy: Variation among populations. DIABETES. vol. 53, A536-A536.
Lorini R, Minicucci L, Napoli F, Padovani P, Bazzigaluppi E, Cherubini V, Bottazzo G, Pozzilli P et al. (2004). HLA screening for type 1 diabetes at birth in the general population in Italy and implementation of a primary prevention trial with vitamin D and cow's milk hydrolysate. (The PREVEFIN trial). DIABETES. vol. 53, A299-A299.
Beyan H, Valorani MG, Valente L, Pozzilli P, Leslie RDG (2004). Plasma 1,25-dihydroxyvitamin D3,one-alpha hydroxylase and vitamin D receptor mRNA in patients with recent-onset type I diabetes. DIABETES. vol. 53, A296-A296.
Crinò A, Schiaffini R, Manfrini S, Mesturino C, Visalli N, Beretta Anguissola G, Suraci C, Pitocco D et al.(2004). A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX). Eur J Endocrinol vol. 150, (5) 719-724.
10.1530/eje.0.1500719
Pozzilli P(2004). Umberto Di Mario, 1948-2004, professor of Endocrinology at the University of Rome, La Sapienza, Co-editor of 'Diabetes and metabolism research and reviews', president of the Italian Society of Diabetes. DIABETES-METAB RES vol. 20, (3) 177-177.
10.1002/dmrr.484
Gentilucci UV, Picardi A, Manfiini S, D'Avola D, Costantino S, Pozzilli P(2004). Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis. Acta Biomed vol. 75, (1) 69-73.
Gale EAM, Bingley PJ, Knip M, Emmett CL, Swankie H, Fewell S, Kearsey P, Schober E et al.(2004). European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. LANCET vol. 363, (9413) 925-931.
10.1016/S0140-6736(04)15786-3
Buzzetti R, Galgani A, Petrone A, Del Buono ML, Erlich HA, Bugawan TL, Lorini R, Meschi F et al.(2004). Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study). Diabetes Metab Res Rev vol. 20, (2) 137-143.
10.1002/dmrr.426
Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS et al.(2004). C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes vol. 53, (1) 250-264.
10.2337/diabetes.53.1.250
Pozzilli P, Leomanni C, Merola KYM (2004). Immunointervention in Type 1 diabetes. PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY. 327-334.
Noble JA, Valdes AM, McGrue Q, Galgani A, Petrone A, Di Cola S, Erlich HA, Pozzilli P et al. (2003). A study of DR-DQ matched T1D cases and controls in a continental Italian population reveals susceptibility effects of DPB1 and HLA-A alleles. AMERICAN JOURNAL OF HUMAN GENETICS. vol. 73, 523-523.
Pozzilli P, Manfrini S, Picardi A(2003). Cow's milk and trials for prevention of Type 1 diabetes. Diabet Med vol. 20, (11) 871-872.
10.1046/j.1464-5491.2003.01080.x
Signore A, Annovazzi A, Giacalone P, Beales PE, Valorani MG, Vestri AR, Ruberti G, Manfrini S et al.(2003). Reduced cumulative incidence of diabetes but not insulitis following administration of chimeric human IL-15-murine IgG2b in NOD mice. Diabetes Metab Res Rev vol. 19, (6) 464-468.
10.1002/dmrr.400
Pozzilli P, Leslie D(2003). Endocrinology and Art. Louise ou la Servante Bretonne. J Endocrinol Invest vol. 26, (10)
10.1007/BF03348207
Pozzilli P(2003). Blessed with exophthalmos in Michelangelo's Last judgment. QJM vol. 96, (9) 688-690.
10.1093/qjmed/hcg095
Mottini G, D'Avola D, Dimbelolo JC, Lumu R, Gallizioli E, Nisita J, Manfrini S, De Clerck M et al.(2003). A hospital survey of the clinical features of diabetes in Congo. Diabetes Nutr Metab vol. 16, (4) 236-242.
Buckley LR, Hawa MI, Beyan H, Valorani MG, Pozzilli P, Leslie RDG (2003). Altered monocyte cyclooygenase expression in non-obese diabetic mice. DIABETOLOGIA. vol. 46, A180-A180.
Visalli N, Sebastiani L, Adorisio E, Conte A, De Cicco AL, D'Elia R, Manfrini S, Pozzilli P et al.(2003). Environmental risk factors for type 1 diabetes in Rome and province. Arch Dis Child vol. 88, (8) 695-698.
10.1136/adc.88.8.695
Valdes A, Buzzetti R, Galgani A, Visalli N, Montemari AL, Bosi E, Meschi F, Lorini R et al. (2003). Investigation of risk factors associated with different HLA genotypes of susceptibility to Type 1 diabetes (The DIABFIN Project). DIABETOLOGIA. vol. 46, A113-A113.
Bugawan TL, Mirel DB, Valdes AM, Panelo A, Pozzilli P, Erlich HA(2003). Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos. Am J Hum Genet vol. 72, (6) 1505-1514.
10.1086/375655
Pozzilli P, Marchini F(2003). Puppet with a voluminous goiter. J Endocrinol Invest vol. 26, (6)
10.1007/bf03345226
Ou DW, Wang XJ, Metzger D, Jobin C, Chantler J, James R, Pozzilli P, Tingle A (2003). Regulation of TRAIL-mediated human beta-cells destruction by FADD and NF-kappa B. DIABETES. vol. 52, A423-A423.
Battelino T, Ursic-Bratina N, Dolzan V, Stopar-Obreza M, Pozzilli P, Krzisnik C, Vidan-Jeras B(2003). The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes. Eur J Immunogenet vol. 30, (3) 223-227.
10.1046/j.1365-2370.2003.00395.x
Visalli N, Crino A, Spera S, Costanza F, Fioriti E, Corbi S, Beretta G, Pozzilli P et al. (2003). The natural history of C-peptide secretion in the first year of type 1 diabetes. DIABETES. vol. 52, A277-A277.
Prisco F, Iafusco D, Lorini R, Minicucci L, Martinucci M, Toni S, Cerrutti F, Rabbone I et al. (2003). Usefulness of blood ketone bodies for monitoring insulin therapy in patients with recent onset type 1 diabetes (a multicenter study). DIABETES. vol. 52, A131-A131.
Pozzilli P, Crino A, Costantino F, Manfrini S, Spera S, Suraci C, Pitocco D, Patera P et al. (2003). Vitamin D supplementation in patients with recent onset type I diabetes: IMDIAB XI trial. DIABETES. vol. 52, A44-A44.
Picardi A, Gentilucci UV, Zardi EM, Caccavo D, Petitti T, Manfrini S, Pozzilli P, Afeltra A(2003). TNF-alpha and growth hormone resistance in patients with chronic liver disease. J Interferon Cytokine Res vol. 23, (5) 229-235.
10.1089/107999003321829944
Picardi A, Gentilucci UV, Zardi EM, Manfrini S, Afeltra A, Pozzilli P (2003). GH-resistance in different stages of chronic liver disease. JOURNAL OF HEPATOLOGY. vol. 38, 67-68.
10.1016/S0168-8278(03)80286-6
Picardi A, Gentilucci UV, Zardi EM, Intelligente F, Manfrini S, Afeltra A, Pozzilli P (2003). Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease. JOURNAL OF HEPATOLOGY. vol. 38, 68-68.
10.1016/S0168-8278(03)80287-8
Pozzilli P, Adorini L(2003). Prevention of type 1 diabetes: where do we start?. J Endocrinol Invest vol. 26, (4) 292-293.
10.1007/BF03345174
Signore A, Picarelli A, Annovazzi A, Britton KE, Grossman AB, Bonanno E, Maras B, Barra D et al.(2003). 123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases. Nucl Med Commun vol. 24, (3) 305-316.
10.1097/01.mnm.0000061052.02423.2c
Flohé SB, Wasmuth HE, Kerad JB, Beales PE, Pozzilli P, Elliott RB, Hill JP, Scott FW et al.(2003). A wheat-based, diabetes-promoting diet induces a Th1-type cytokine bias in the gut of NOD mice. Cytokine vol. 21, (3) 149-154.
10.1016/S1043-4666(02)00486-6
Beyan H, Valorani MG, Pozzilli P(2003). --to: Gale EAM (2002) A missing link in the hygiene hypothesis? Diabetologia 45:588-592. Diabetologia vol. 46, (2) 301-302.
10.1007/s00125-002-1019-y
Pozzilli P, Crinò A, Schiaffini R, Manfrini S, Fioriti E, Coppolino G, Pitocco D, Visalli N et al.(2003). A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8). Diabetes Technol Ther vol. 5, (6) 965-974.
10.1089/152091503322641006
POZZILLI P, Valdes AM, Noble JA, McGrue Q, Galgani A, Cola SD, Erlich HA, Buzzetti R(2003). A study of DR-DQ matched T1D cases and controls in a continental Italian population reveals susceptibility effects of DPB1 and HLA-A alleles. Hum. Immunol. vol. 64, S143-S143.
Picardi A, Pozzilli P(2003). Dynamic tests in the clinical management of diabetes. J Endocrinol Invest vol. 26, (7 Suppl) 99-106.
Monetini L, Barone F, Stefanini L, Petrone A, Walk T, Jung G, Thorpe R, Pozzilli P et al.(2003). Establishment of T cell lines to bovine beta-casein and beta-casein-derived epitopes in patients with type 1 diabetes. J Endocrinol vol. 176, (1) 143-150.
10.1677/joe.0.1760143
Buzzetti R, Pozzilli P, Di Mario U, Ballerini C, Massacesi L(2002). Multiple sclerosis and Type I diabetes. Diabetologia vol. 45, (12) 1735-1736.
10.1007/s00125-002-0967-6
Ou D, Metzger DL, Wang X, Huang J, Pozzilli P, Tingle AJ(2002). TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction. Diabetologia vol. 45, (12) 1678-1688.
10.1007/s00125-002-0926-2
Beales PE, Elliott RB, Flohé S, Hill JP, Kolb H, Pozzilli P, Wang G-S, Wasmuth H et al.(2002). A multi-centre, blinded international trial of the effect of A(1) and A(2) beta-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes. Diabetologia vol. 45, (9) 1240-1246.
10.1007/s00125-002-0898-2
Dorff G, Meyer G, Krone D, Pozzilli P, Zühlke H(2002). Neuronal NO synthase and its inhibitor PIN are present and influenced by glucose in the human beta-cell line CM and in rat INS-1 cells. Biol Chem vol. 383, (9) 1357-1361.
10.1515/BC.2002.154
Petrone A, Battelino T, Krzisnik C, Bugawan T, Erlich H, Di Mario U, Pozzilli P, Buzzetti R(2002). Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies. Tissue Antigens vol. 60, (3) 244-253.
10.1034/j.1399-0039.2002.600306.x
Beales PE, Castri F, Valiant A, Rosignoli G, Buckley L, Pozzilli P(2002). Adrenalitis in the non-obese diabetic mouse. Autoimmunity vol. 35, (5) 329-333.
10.1080/0891693021000003189
Monetini L, Cavallo MG, Manfrini S, Stefanini L, Picarelli A, Di Tola M, Petrone A, Bianchi M et al.(2002). Antibodies to bovine beta-casein in diabetes and other autoimmune diseases. Horm Metab Res vol. 34, (8) 455-459.
10.1055/s-2002-33595
Klitz W, Bugawan TL, Panelo A, Solfelix CM, Buzzetti R, Pozzilli P, Steiner L, Alejandrino M et al.(2002). Association of CTLA-4 variation with type I diabetes in Filipinos. Immunogenetics vol. 54, (5) 310-313.
10.1007/s00251-002-0471-7
Manfrini S, Coppolino G, Costanza F, Modi P, Montemari A, Pozzilli P (2002). Biokinetics of oral spray insulin: comparison with regular and lispro insulin in patients with Type 1 diabetes. DIABETOLOGIA. vol. 45, A262-A262.
Visalli N, Crino A, Schiaffini R, Matteoli M, Patera P, Pitocco D, Ghirlanda G, Manfrini S et al. (2002). C-peptide two years after diagnosis of Type 1 diabetes: the effect of nicotinamide and intensive insulin therapy. DIABETOLOGIA. vol. 45, A119-A119.
Coppolino G, Manfrini S, Schiaffini R, Crino A, Merola MK, Valente L, Visalli N, Pozzilli P et al. (2002). Leptin levels in the early phases of Type 1 diabetes could explain insulin resistance in the early stages of the disease in female patients. DIABETOLOGIA. vol. 45, A208-A209.
Buzzetti R, Galgani A, Petrone A, Di Mario U, Multari G, Lorini R, Bosi E, Cristaldi A et al. (2002). Newborn screening for prediction of Type 1 diabetes genetic risk in continental Italy (Diabfln Study). DIABETOLOGIA. vol. 45, A49-A49.
Buckley LR, Hawa MI, Beyan H, Pozzilli P, Leslie RDG (2002). Role of monocyte cyclooxygenase-2 in Non-Obese Diabetic mice. DIABETOLOGIA. vol. 45, A116-A116.
Pozzilli P(2002). The DPT-1 trial: a negative result with lessons for future type 1 diabetes prevention. Diabetes Metab Res Rev vol. 18, (4) 257-259.
10.1002/dmrr.316
Manfrini S, Crino A, Fredrickson L, Pozzilli P, IMDIAB Grp(2002). CSII versus intensive insulin therapy at onset of type 1 diabetes: The IMDIAB 8 two-year randomised trial. DIABETES vol. 51, A4-A4.
Manfrini S, Modi P, Fioriti E, Coppolino G, Costanza F, Pozzilli P(2002). Evaluation of the compliance in the use of oral spray insulin in patients with Type-1 diabetes. DIABETES vol. 51, A440-A440.
Pozzilli P, Cherubini V, Pinelli A, Valente L, Suraci C(2002). Low levels of 1,25-dihydroxyvitamin D3 in patients with recent onset type 1 diabetes living in a Mediterranean country. DIABETES vol. 51, A289-A289.
Pozzilli P, Modi P, Manfrini S, Coppolino G, Costanza F, Fioriti E(2002). Pharmacokinetics of oral spray insulin vs. regular insulin and lispro insulin in Type-1 diabetes. DIABETES vol. 51, A48-A48.
Visalli N, Suraci C, Leotta S, Pozzilli P, Imdiab Group(2002). Residual beta cell function as assessed by baseline C-peptide is an independent factor from glucose levels at the time of blood sampling. DIABETES vol. 51, A427-A428.
Ou DW, Wang XJ, Metzger D, Huang JQ, Pozzilli P, Tingle A(2002). TRAIL death signal transduction pathway mediated human beta-cell destruction. DIABETES vol. 51, A453-A453.
Bugawan TL, Klitz W, Alejandrino M, Ching J, Panelo A, Solfelix CM, Petrone A, Buzzetti R et al.(2002). The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos. Tissue Antigens vol. 59, (6) 452-469.
10.1034/j.1399-0039.2002.590602.x
Nisticò L, Giorgi G, Giordano M, Galgani A, Petrone A, D'Alfonso S, Federici M, Di Mario U et al.(2002). IL12B polymorphism and type 1 diabetes in the Italian population: a case-control study. Diabetes vol. 51, (5) 1649-1650.
10.2337/diabetes.51.5.1649
Bottini N, Meloni GF, Borgiani P, Giorgini A, Buzzetti R, Pozzilli P, Lucarelli P, Gloria-Bottini F(2002). Genotypes of cytosolic low-molecular-weight protein-tyrosine-phosphatase correlate with age at onset of type 1 diabetes in a sex-specific manner. Metabolism vol. 51, (4) 419-422.
10.1053/meta.2002.31317
Ou D, Metzger DL, Wang X, Pozzilli P, Tingle AJ(2002). beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetic patients: autoaggressive effector T cells damage human CD56(+) beta cells by HLA-restricted and non-HLA-restricted pathways. Hum Immunol vol. 63, (4) 256-270.
10.1016/S0198-8859(02)00372-5
Beales PE, Pozzilli P(2002). Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev vol. 18, (2) 114-117.
10.1002/dmrr.262
Misani P, Pozzilli P(2002). Bather. Fernando Botero--Medellín 1932. J Endocrinol Invest vol. 25, (2)
10.1007/bf03343988
Leslie RDG, Pozzilli P (2002). An introduction to new advances in diabetes. Diabetes Metab Res Rev. vol. 18 Suppl 1, S1-S6.
10.1002/dmrr.203
Bugawan TL, Alejandrino M, Panelo A, Solfelix CM, Buzzetti R, Pozzilli P, Mirel D, Reynolds R et al.(2002). Genetics of type 1 diabetes among flipinos: Association studies of HLA and non-HLA candidate genes. TISSUE ANTIGENS vol. 59, 53-54.
Pozzilli P, Mesturino CA, Crino A, Gross TM, Jeng LM, Visalli N, IMDIAB Group(2001). Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males?. Eur J Endocrinol vol. 145, (6) 757-761.
10.1530/eje.0.1450757
Sebastiani L, Visalli N, Adorisio E, D'Elia R, Conte A, Pozzilli P(2001). [Type 1 diabetes in Lazio. Note 2 -- case control study of risk factors]. Ann Ig vol. 13, (6) 523-530.
Bugawan TL, Alejandrino M, Mirel DB, Panelo A, Solfelix CM, Pozzilli P, Buzzetti R, Reynolds RL et al.(2001). Association of specific IL4 receptor SNPs with type 1 diabetes in Filipinos. AM J HUM GENET vol. 69, (4) 403-403.
Mango R, Guarino S, D'Apice R, Amati F, Sangiuolo F, Pozzilli P, Bottazzo G, Crino A et al.(2001). Mutational analysis of AIRE gene in APS2 patients. AM J HUM GENET vol. 69, (4) 580-580.
Sebastiani L, Adorisio E, Visalli N, Conte A, D'Elia R, Pozzilli P(2001). [Type I diabetes in Lazio. Note 1: incidence in 1989-1998]. Ann Ig vol. 13, (5) 393-398.
Beales PE, Rosignoli G, Buckley LR, Pozzilli P(2001). Admistration of vitamin D3 during pregnancy and early life did not reduce diabetes incidence in NOD/Ba mice. DIABETOLOGIA vol. 44, A100-A100.
Pozzilli P, Di Mario U(2001). Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care vol. 24, (8) 1460-1467.
10.2337/diacare.24.8.1460
Monetini L, Cavallo MG, Sentinelli F, Stefanini L, Bonifacio E, Sarugeri E, Bosi E, Pozzilli P et al.(2001). Cytokine profiles and IgG-IA subclasses response in type 1 diabetic patients treated with oral insulin. DIABETOLOGIA vol. 44, A151-A151.
Cavallo MG, Coppolino G, Romeo S, Manfrini S, Modi P, Pozzilli P(2001). Oral spray insulin in patients with Type 1 diabetes: Comparison with regular insulin. DIABETOLOGIA vol. 44, A213-A213.
Cavallo MG, Coppolino G, Romeo S, Pozzilli P(2001). Inhaled insulin in type 1 diabetes. Lancet vol. 357, (9272)
10.1016/s0140-6736(00)05051-0
Pozzilli P, Mesturino CA, Crino A, Ciampalini P, Cervoni M, Coppolino G, Manfrini S, Suraci MC et al.(2001). Nicotinamide and vitamin E versus Nicotinamide alone as adyuvant therapy at onset of Type 1 diabetes (IMDIAB IX trial). DIABETES vol. 50, A71-A71.
Cavallo MG, Romeo S, Coppolino G, Modi P, Pozzilli P(2001). Oral spray insulin in patients with Type 1 diabetes and residual beta cell function. DIABETES vol. 50, A108-A108.
Genovese S, Goncalves D, Cavallo GM, Purrello F, Anello L, Rotella CM, Bardini G, Riccardi G et al.(2001). Prevalence and clinical characteristics of adult onset diabetes associated with GAD65 autoantibodies. Screening of a large sample of patients attending diabetic clinics in Italy. DIABETES vol. 50, A94-A94.
Ou DW, Metzger D, Wang XJ, Pozzilli P, Tingle A(2001). beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetes patients: Autoaggressive effector T cells damage human CD56+p cells by HLA-Restricted and Non-HLA-Restricted pathways. DIABETES vol. 50, A264-A264.
Crinò A, Cavallo MG, Corbi S, Mesturino CA, Ferrazzoli F, Coppolino G, Bizzarri C, Cervoni M et al.(2001). Intradermal skin test with diabetes specific antigens in patients with type 1 diabetes. Clin Exp Immunol vol. 123, (3) 382-386.
10.1046/j.1365-2249.2001.01480.x
Pozzilli P(2001). A ferocious cretin with voluminous goiter. J ENDOCRINOL INVEST vol. 24, (2) 137-137.
10.1007/BF03343829
Cavallo MG, Romeo S, Coppolino G, Pozzilli P(2001). Continuous glucose monitoring during the European Soccer cup semifinal, Italy against Holland. Diabetologia vol. 44, (2)
10.1007/s001250051611
Pozzilli P(2001). Endocrinology and art. "A ferocious cretin with voluminous goiter". Morazzone, circa 1600. J Endocrinol Invest vol. 24, (2)
10.1007/bf03343829
Multari G, Werner B, Cervoni M, Lubrano R, Costantino F, Demiraj V, Pozzilli P(2001). Peritoneal dialysis in an infant with type 1 diabetes and hyperosmolar coma. J Endocrinol Invest vol. 24, (2) 104-106.
10.1007/BF03343822
Pozzilli P, Manfrini S, Monetini L(2001). Biochemical markers of type 1 diabetes: clinical use. Scand J Clin Lab Invest Suppl vol. 235, 38-44.
10.1080/003655101753352031
Monetini L, Cavallo MG, Stefanini L, Ferrazzoli F, Bizzarri C, Marietti G, Curro V, Cervoni M et al.(2001). Bovine beta-casein antibodies in breast- and bottle-fed infants: their relevance in Type 1 diabetes. Diabetes Metab Res Rev vol. 17, (1) 51-54.
10.1002/1520-7560(2000)9999:9999<::AID-DMRR156>3.0.CO;2-H
Return to top